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1. Introduction 1
1. Introduction 
1.1 The organization of the mammalian immune system 
The mammalian immune response can generally be subdivided into three 
interdependent limbs, namely the innate immune response, the humoral response 
and the cell-mediated response. The innate immune system is believed to provide a 
first barrier against the spread of pathogens within a newly infected host. Thereby it 
counteracts the establishing infection and contributes to an early clearance of the 
pathogen. However, the term “innate immune response” describes a very diverse 
repertoire of mechanisms, among them complement-mediated killing of bacteria 
(Gasque et al, 2004), secretion of peptide antibiotics (Boman et al, 1995), elimination 
of extracellular pathogens through phagocytic uptake by macrophages (Hingley-
Wilson et al, 2000) and NK-cell mediated cytotoxicity (Ljunggren et al, 1990). The 
innate immune system identifies its microbial targets mainly by the recognition of 
relatively invariable so-called pathogen-associated molecular patterns (PAMPs) 
(Janeway et al, 2002) through a huge number of specialized receptors, including the 
Toll-like and NOD family of receptors (Janeway et al, 2002; Tschopp et al, 2003). 
Numerous cell types including macrophages, NK cells and epithelial cells contribute 
effector functions to this limb of the immune system and in addition many (perhaps 
all) non-immune cells can acquire an antiviral state upon γ-interferon treatment, a 
phenomenon commonly referred to as cell-autonomous resistance (MacMicking et al, 
2004; Weber et al, 2004). The humoral immune response is mediated by the B cell 
population, which secretes an enormously diverse repertoire of antibodies (Calame 
et al, 2003). Antibodies neutralize toxins (Little et al, 1988; Wild et al, 2003), block the 
adhesion of pathogens to mucosal surfaces (Kunisawa et al, 2005) or opsonize 
pathogens to mark them for phagocytic uptake (or immediate destruction) (Stuart et 
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al, 2005). Thus, an antibody-mediated immune response is predominantly directed 
against extracellular pathogens. According to the theory of clonal selection each 
individual B cell produces only a single type of antibody. The mature gene that 
encodes an antibody is generated by rearrangement of DNA (Sadofsky et al, 2001) 
and its expression gives either rise to the B cell receptor (BCR), which is anchored in 
the plasma membrane or to the secreted antibody, which is its soluble analog 
(Cambier et al, 1992). Antibodies can recognize the antigens they are targeted 
against in their native conformation. This distinguishes them fundamentally from the 
related T cell receptors (TCRs) which require both processing of their epitopes and 
presentation of their peptide antigens in the context of a major histocompatibility 
(MHC) class I or II molecule (Myers et al, 1991). TCR diversity is generated by a site-
directed DNA recombination process largely similar to the mechanism that generates 
the high variety within the antibody repertoire (Sadofsky et al, 2001). T cells originate 
from precursor stem cells in the bone marrow and migrate during their early 
development to the thymus where they differentiate (Bommhardt et al, 2004). There 
they undergo both positive as well as negative selection with the consequence that 
only MHC-restricted cells survive that do not recognize self-antigen with high affinity 
(Sebzda et al, 1999). MHC class II-restricted T cells become selected to the CD4+ 
lineage and henceforth recognize peptide antigens that (largely) derive from 
extracellular proteins ingested by professional phagocytic cells. These include 
dendritic cells, macrophages and B cells. Accordingly, these cell types express high 
levels of MHC class II. The proteolytic processing of MHC class II-presented antigens 
occurs in compartments along the endocytic route (e.g. endosomes or lysosomes) 
and requires the activity of a diverse set of enzymes, among them cysteine proteases 
(e.g. cathepsins S, L, B, H and F) and the γ-interferon-induced lysosomal thiol 
reductase (GILT) (Watts et al, 2004). Two major CD4+ lineages exist: inflammatory 
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TH1 cells and TH2 helper cells. The former secrete γ-interferon and activate 
macrophages to become bactericidal whereas the latter activate B cells to secrete 
antibodies (Dong et al, 2000). Thus, CD4+ T-lymphocytes represent an important 
connection between cell-mediated immunity on the one hand and innate or humoral 
immune response on the other hand. In contrast, MHC class I-restricted T cells 
become selected to the CD8+ lineage. The vast majority of antigenic peptides that 
are recognized by CD8-positive T cells in combination with MHC class I are 
breakdown products of the proteolytic degradation machinery in the cytosol 
(Leonhardt et al, 2003; Pamer et al, 1998). Accordingly, the cell-mediated immune 
response exerted by cytotoxic (CD8+) T lymphocytes (CTLs) is mainly directed 
against intracellular pathogens, primarily viruses and some bacteria. In addition CTLs 
make a major contribution to the elimination of tumor cells. In line with this, MHC 
class I molecules (in contrast to their class II counterparts) are expressed on the 
surface of all nucleated cells. The recognition of non-self peptide by a CTL at the 
surface of an infected (or malignant) cell leads to the release by the T cell of granules 
containing perforin and granzymes that have membrane-disrupting and apoptosis-
inducing activity (Trapani et al, 2002). Using this pathway and/or a FasL-induced 
mechanism the CTL activates the apoptotic program of the infected (or malignant) 
target cell (Trapani et al, 2002). Therefore it is not surprising that many viral (Hewitt 
et al, 2003; Lybarger et al, 2005) but also bacterial (Neumeister et al, 2005; Qimron 
et al, 2004) pathogens have developed a huge number of immune evasion strategies 
that subvert the class I antigen presentation pathway. In addition, tumor cells also 
frequently down-modulate class I surface levels to avoid their recognition by CTLs 
(Bubenik et al, 2003). However, during an infection (or the onset of cancer) the three 
limbs of the immune system synergistically attack intruding microbes (or malignant 
cells) and in most cases efficiently protect the host organism from disease.  
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1.2 The processing of MHC class I-presented antigenic peptide ligands 
Fig. 1 The MHC class I antigen presentation pathway 
Intracellular proteins (1) are degraded by the proteasome in the cytosol (2) and the resulting 
oligopeptides are subsequently translocated into the ER by the peptide transporter TAP (3). There 
they are loaded onto empty MHC class I molecules (3). These are at that stage part of a multi-
protein complex, the so-called MHC class I peptide loading complex (PLC). Within this complex 
TAP is bridged to MHC class I by tapasin. Additionally the PLC comprises the lectin chaperone 
calreticulin and the oxidoreductase ERp57. Upon binding of a peptide ligand the loaded MHC 
class I molecule dissociates from the PLC (4) and migrates to the plasma membrane (7). On this 
way it passes the Golgi apparatus (5) and the trans-Golgi network (6). 
As mentioned above antigenic peptide ligands for MHC class I mostly derive from the 
degradation of intracellular proteins in the cytosol (Pamer et al, 1998). The major 
endoprotease that contributes oligopeptides to this pathway is the proteasome  
(Fig. 1) (Goldberg et al, 2002; Kloetzel et al, 2001). Moreover, in the context of some 
MHC class I alleles the tripeptidyl peptidase II (TPP II) is supposed to play an 
important role for the endoproteolytic generation of antigens (Seifert et al, 2003). 
However, proteasomal activity yields only a small fraction of peptides that have the 
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appropriate length of 8 to 10 amino acids to bind an MHC class I molecule. Namely, 
more than 70% of the oligopeptides generated by the proteasome are too short, 
whereas 15% exceed the size of a suitable class I ligand (Kisselev et al, 1999). 
Aminopeptidases can trim the latter population to a fitting length (Goldberg et al, 
2002). Currently, for several cytosolic aminopeptidases a role in the MHC class I 
antigen presentation pathway is discussed, among them puromycin-sensitive 
aminopeptidase (Levy et al, 2002; Stoltze et al, 2000), bleomycin hydrolase (Stoltze 
et al, 2000), TPP II (Levy et al, 2002) and γ-interferon inducible leucine 
aminopeptidase (LAP) (Beninga et al, 1998). Furthermore, upon induction with γ-
interferon the proteolytic machinery in the cytosol becomes modified (presumably) for 
adjusting it to the requirements of the immune system in the context of an infection. 
Particularly, the composition of the proteasome changes by the incorporation of three 
new γ-interferon-induced subunits and the regulator PA28. The resulting so-called 
immunoproteasome is distinct from the regular housekeeping proteasome with 
respect to its cleavage specificity and hence the peptide repertoire that it generates 
(Cascio et al, 2001). Consistently, the production of several important viral or tumor-
associated peptide antigens specifically depends on the activity of this modified 
protease (Cerundolo et al, 1995; Lautscham et al, 2003; Schultz et al, 2002) or the 
presence of PA28 (Sijts et al, 2002). Interestingly, the activity of the 
immunoproteasome was shown to yield more N-terminally extended precursors of an 
intensively investigated model peptide ligand for MHC class I when compared to its 
constitutive counterpart (Cascio et al, 2001). However, the finding that the 
incorporation of the immuno-subunits into the proteasome conversely abrogates the 
production of some epitopes (Morel et al, 2000) queries the view that 
immunoproteasomes are always the “better” proteasomes under all circumstances. 
During the early phase (approx. one week) of a viral or bacterial infection constitutive 
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proteasomes were reported to become gradually replaced by their immuno-
counterparts (Khan et al, 2001). Thus, the combined presence of both in the 
beginning of the pathogenic challenge may broaden the spectrum of antigenic 
peptide ligands produced, thereby increasing the efficiency of an immune response. 
After their generation in the cytosol oligopeptides have to traverse the endoplasmic 
reticulum (ER) membrane before they can be loaded onto class I (Fig. 1). The major 
route used for entry into the ER is via the peptide transporter associated with antigen 
processing (TAP) which resides in the ER membrane (Leonhardt et al, 2003; Schmitt 
et al, 2000). Although some very hydrophobic class I ligands were reported to get 
access to class I without the need for this transporter (Lautscham et al, 2001; 
Lautscham et al, 2003), the vast majority of cytosolic peptides essentially depends on 
the activity of TAP for their translocation into the ER. This becomes evident by 
markedly decreased MHC class I surface levels on cells of TAP-deficient individuals 
as a consequence of an almost stagnant peptide supply into the endoplasmic 
reticulum (Gadola et al, 2000). However, some MHC class I alleles as HLA-A2 can 
efficiently associate with peptides derived from signal sequences in a TAP-
independent manner (Wölfel et al, 2000). After transport into the ER N-terminally 
extended class I ligands can be further trimmed by the γ-interferon-inducible 
aminopeptidase ERAP1 until a suitable length for loading onto class I is reached 
(Saric et al, 2002; Serwold et al, 2002). In the ER peptide-receptive MHC class I 
molecules associate with TAP and several chaperones to form the so-called MHC 
class I peptide loading complex (PLC) (Fig. 1 and 4) (Leonhardt et al, 2003; Wright et 
al, 2004). This complex retains class I in the ER as long as the loading with a high 
affinity peptide ligand has occurred (see below). Upon binding of such a ligand the 
MHC class I molecule dissociates from the PLC and migrates along the standard 
secretory route to the cell surface, where it presents its peptide to CTLs (Fig. 1) 
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(Yewdell et al, 2003). An unexpected surprise for the field was the finding that some 
antigenic peptides for class I can also be generated in the trans-Golgi network (TGN) 
by furin, a member of the proprotein convertase family (Gil-Torregrosa et al, 1998; 
Gil-Torregrosa et al, 2000). However, to what extent this pathway contributes to the 
overall repertoire of surface-presented peptides and how these specific ligands are 
loaded onto class I has remained elusive.  
Taken together, MHC class I molecules present peptides derived from the 
degradation of intracellular proteins on the cell surface for perusal by CD8+ T cells. 
This process allows CTLs to monitor the current protein content of a host cell and to 
identify (and kill) cells that harbor abnormal or non-self (e.g. of viral origin) proteins. 
To sacrifice a virally infected or malignant cell is a necessary evil that protects the 
host from spreading of the infection to other cells or the development of a life-
threatening tumor. 
 
1.3 The transporter associated with antigen processing (TAP) 
The peptide transporter TAP (Fig. 2) is a member of the ATP binding cassette (ABC) 
transporter family (Schmitt et al, 2000). ABC transporters have been isolated from all 
three kingdoms of life, where they translocate diverse substances including vitamins, 
drugs, ions, amino acids, peptides, sugars or lipids across biological membranes 
(Garmory et al, 2004; Van der Does et al, 2004). Irrespective of the substrate 
specificity, which is clearly distinct among individual members of this protein family all 
ABC transporters share an identical four domain organization comprising two 
nucleotide binding domains (NBDs) and two transmembrane domains (TMDs) 
(Stefkova et al, 2004). TAP also possesses this characteristic four domain 
composition (Fig. 2A and Fig. 2B) (Schmitt et al, 2000). Its NBDs bind and hydrolyze 
ATP (Chen et al, 2003; Knittler et al, 1999; Saveanu et al, 2001; Schmitt et al, 2000) 
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A 
Fig. 2 The structural organization of the ABC transporter TAP 
(A) The TAP transporter is a heterodimer that consists of the two subunits TAP1 (depicted in 
black) and TAP2 (depicted in red). Either chain contributes an N-terminal transmembrane domain 
(TMD) and a C-terminal nucleotide binding domain (NBD) to the assembled transporter. In both, 
TAP1 and TAP2, the TMD can be further subdivided into the N-domain at the extreme N-terminus 
(involved in the tapasin interaction) and an inner core TMD, comprising 6 α-helices (involved in 
peptide binding and the formation of the translocation pore). The NBD binds and hydrolyzes ATP 
to energize the peptide translocation into the ER. (B) Model of the TAP transport pore. The closed 
conformation of the lipid A-transporter MsbA from Vibrio cholera (Chang et al, 2003) served as a 
template to predict the arrangement of the putative six transmembrane segments of the TAP core 
TMD. C) MHC class I surface expression on T1 cells expressing human TAP and their TAP-
deficient derivative T2, reconstituted with rat TAPa. T1 cells or T2 transfectants were incubated 
with the monoclonal anti-MHC class I-antibody 4E followed by FITC-labeled secondary antibody to 
determine the surface expression of HLA-B5 (filled histograms). To control for the specificity of the 
primary antibody T2(ratTAP) cells were briefly exposed to acidic buffer for removal of assembled 
surface MHC class I molecules before processing the cells for flow cytometry. Background staining 
was analyzed by incubating with secondary antibody alone (non-filled histograms). 
B 
4 TM-segments 6 + 6 core TM-segments 3 TM-segments
N-domain N-domaintransport pore C 
to energize the peptide translocation process, whereas its TMDs contain the 
substrate binding site and form the translocation pore (Fig. 2B; Nijenhuis et al, 1996). 
TAP is a heterodimer consisting of two homologous polypeptides, TAP1 and TAP2. 
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Each of these subunits contributes one NBD and one TMD to the assembled 
transporter (Fig. 2A). Both TAP chains are essential for peptide binding and transport 
(Arora et al, 2001; Meyer et al, 1994; Momburg et al, 1992). Sequential hydrolysis of 
ATP by TAP1 and TAP2 has been proposed to drive the translocation of peptide 
across the ER membrane and to restore the ground state of the transporter, which is 
characterized by high affinity for cytosolic substrates (Alberts et al, 2001). The TMDs 
of TAP1 and TAP2 are predicted to comprise 10 and 9 transmembrane helices, 
respectively (Schmitt et al, 2000). The 6 inner membrane spanning helices of both 
TAP subunits are designated as the core TMD, since they are sufficient to allow for 
the formation of a functional substrate binding site and translocation pore in the 
assembled transporter (Koch et al, 2004). The N-terminal extensions (N-domains) of 
the TMDs, (presumably) comprising 4 transmembrane helices in TAP1 and 3 
transmembrane helices in TAP2 function as docking sites for tapasin (Koch et al, 
2004). The preferred substrates for the transporter are peptides with a length of 8 to 
12 amino acids (Abele et al, 2004). Thus, TAP most efficiently delivers those 
peptides into the ER that have an optimal size for binding to MHC class I. With 
respect to the amino acid sequence of its substrates TAP has been reported to be 
highly promiscuous. However, the nature of the C-terminal residue and to a minor 
extent of the first three N-terminal residues plays a role for peptide binding (and most 
likely transport) by TAP (Schmitt et al, 2000). Importantly, human TAP and rat TAPa 
were both shown to be permissive for peptides with any C-terminus with the 
exception of proline (Schmitt et al, 2000), suggesting that both transporters 
translocate a similar set of peptides (Momburg et al, 1994; Pamer et al, 1998). In line 
with this, the human T1 cell line, which expresses the human TAP transporter and its 
derivative T2(ratTAP), which expresses the rat TAPa transporter have equal levels of 
MHC class I at the cell surface (Fig. 2C), indicating that human TAP and rat TAPa are 
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functionally equivalent. The major function of TAP is to supply ER-resident MHC 
class I molecules with antigenic ligands mostly generated by the proteasome in the 
cytosol. Since its inhibition (or absence) results in a dramatic loss of MHC class I 
surface levels (Ahn et al, 1997; Radosevich et al, 2003) TAP must be considered a 
bottleneck of the class I antigen presentation pathway in most cells. Therefore, the 
peptide transporter may be expected to be a major target for viral evasion strategies 
and indeed several viral effectors have been identified that interfere in one or the 
other way with the function of TAP (Lybarger et al, 2005; Momburg et al, 2002b). 
Taken together, TAP is a central component of the cell-mediated immune response 
that provides an (almost) essential connection between the proteolytic degradation 
machinery in the cytosol and peptide-receptive MHC class I molecules in the ER.  
 
1.4 MHC class I molecules 
An MHC class I molecule is defined as a non-covalently associated trimer consisting 
of the membrane-anchored MHC class I heavy chain, the soluble light chain called 
β2-microglobulin and a peptide ligand, usually of 8 to 10 amino acids (Pamer et al, 
1998). The heavy chain is a 43 kDa transmembrane glycoprotein and consists of 
three domains: α1, α2 and α3. The membrane-proximal α3-domain, as well as the β2-
microglobulin adopts a standard immunoglobulin-like fold and both comprise the 
conserved disulfide bond classically found in these domains (Dick et al, 2004). The 
peptide binding groove is part of the α1- and the α2-domain. The floor of this pocket 
consists of a β-sheet whereas either side is lined by an α-helix (Dick et al, 2004). The 
α2-domain comprises the third disulfide-bridge of an MHC class I molecule (Dick et 
al, 2004). This disulfide-bridge lies in close proximity to the N-terminus of the bound 
peptide ligand (see below). The MHC class I heavy chain is both polygenic and 
extremely polymorphic (Adams et al, 2000). The human MHC locus on chromosome 
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6 encodes three different heavy chain genes, namely HLA-A, HLA-B and HLA-C 
(Adams et al, 2000). The human genome is diploid and hence the extensive 
polymorphism among the heavy chain genes promotes the expression of 6 different 
MHC class I alleles per individual. The association of peptide ligands with an MHC 
class I molecule occurs mainly through the insertion of so-called anchor residues into 
specific pockets in the peptide binding groove (Achour et al, 1998; Kjer-Nielsen et al, 
2002). The presence of the correct anchor residues within a ligand (e.g. frequently 
the C-terminus) is a prerequisite for a peptide antigen to bind a given MHC class I 
allele. Since the polymorphism in the MHC class I heavy chain largely concentrates 
on the peptide binding groove, each class I allele has its particular requirements for 
specific anchor residues. The consequence is that different MHC class I alleles bind 
different sets of peptides. In this regard the expression of 6 dissimilar alleles by most 
individuals (and the expression of numberless alleles within a human population) 
increases the number of pathogenic epitopes to that the cell-mediated immune 
system can respond. Thus, both MHC class I polymorphism and the existence of 
multiple class I loci in the genome create an advantage for the organism (or in a 
broader sense for the population) that improves the host defense against microbial 
intruders as viruses or intracellular bacteria. Indeed, the presence of some class I 
alleles was reported to predispose individuals to (or protect individuals from) specific 
diseases (Jeffery et al, 2000; Schrier et al, 1995) whereas others appear to affect the 
course of the disease (Hendel et al, 1999). However, the class I polymorphism does 
not only expand the antigenic peptide repertoire presented at the cell surface for 
immuno-surveillance by CTLs. Additionally, MHC class I alleles were reported to 
substantially differ in their requirements for the presence of a functional PLC to 
acquire stable binding peptides (Peh et al, 1998). In this regard HLA-B5 is an 
example for an allele that essentially depends on the presence of tapasin for 
 
1. Introduction 12
establishing high class I surface levels (Gao et al, 2004; Grandea et al, 1997), 
whereas HLA-B27 appears to be virtually tapasin-independent in this regard (Peh et 
al, 1998). Since some viruses are known to interfere with the proper formation of a 
PLC (Lybarger et al, 2005), the class I polymorphism may also be part of a cellular 
counter strategy in providing alleles that stay functional even under these specific 
circumstances when viruses attempt to subvert the standard antigen presentation 
pathway.  
 
1.5 Lectin chaperones, ERp57 and the oxidative folding pathway in the ER 
The two lectin chaperones calnexin and calreticulin act together with the 
oxidoreductase ERp57 in an oxidative folding pathway for newly synthesized 
glycoproteins in the ER (Fig. 3) (Kleizen et al, 2004). After the initial transfer of a 
sugar tree to an acceptor asparagine within a nascent substrate protein the first step 
is that α-glucosidases Ι and ΙΙ sequentially trim two glucose residues from the tree to 
generate a monoglucosylated glycan. This immature carbohydrate structure, which is 
typically found on newly synthesized and therefore not yet completely folded 
glycoproteins is subsequently recognized by either calnexin or calreticulin (High et al, 
2000; Kleizen et al, 2004). Both of these chaperones associate and act in synergy 
together with the thiol-disulfide oxidoreductase ERp57, which facilitates the coupling 
of substrate oxidation and folding (Molinari et al, 1999; Oliver et al, 1999). After 
eventual ERp57-mediated introduction of disulfide bonds the folding cycle is 
completed with the action of α-glucosidase ΙΙ on the substrate protein, which 
removes the terminal glucose on the glycan. Subsequently, the folded glycoprotein is 
released from calnexin or calreticulin. In the case that folding is not yet completed the 
glycoprotein substrate is recognized by UGGT (UDP glucose:glycoprotein 
glucosyltransferase), which acts as a folding sensor in the pathway and can 
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reglucosylate the substrate to make it reenter a new calnexin/calreticulin folding cycle 
(High et al, 2000; Kleizen et al, 2004).   
Fig. 3 The oxidative folding cycle for glycoproteins in the ER 
Newly synthesized glycoproteins initially carry glycan precursors with the carbohydrate structure 
GlcNAc2Man9Glc3 (1). This sugar tree is trimmed by the sequential action of α-glucosidases Ι and 
ΙΙ, thereby generating a mono-glucosylated oligosaccharide (2). This oligosaccharide is recognized 
by the membrane-anchored lectin chaperone calnexin (CNX) (3a) or its soluble homolog 
calreticulin (CRT) (3b). Both chaperones share the capability to recruit the oxidoreductase ERp57 
into the resulting folding complexes (3a/3b) that promotes the proper formation of disulfide bridges 
within its substrate proteins (4a/4b). The removal of the terminal glucose residue from the sugar 
tree by α-glucosidase ΙΙ releases the polypeptide from the respective lectin chaperone (5). 
Reglucosylation can occur (dashed line) if the folding sensor UGGT determines that the 
glycoprotein is not yet properly folded (6). Subsequently, the latter can enter a new CNX/CRT-
mediated folding cycle.  
 
1.6 The assembly and function of the MHC class I peptide-loading complex 
During the sequential assembly of the PLC MHC class I molecules interact at 
multiple stages with lectin chaperones and the oxidoreductase ERp57 (Fig. 4). The 
first contact occurs between calnexin and the nascent class I heavy chain, 
presumably to facilitate proper folding of the latter during co-translational protein 
translocation into the ER (Dick et al, 2004; Tector et al, 1995; Vassilakos et al, 1996). 
The fact that ERp57 is found in these early assembly complexes (Farmery et al, 
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Fig. 4 Hypothetical model on the assembly of the MHC class I-peptide loading complex 
Glycosylated MHC class I heavy chains (HC) (1) associate with calnexin and ERp57 in the ER (2). 
Both chaperones together promote the proper oxidative folding of the HC. The subsequent 
interaction with β2-microglobulin (3) leads to the disassembly of this initial folding complex through 
the release of calnexin (and probably also ERp57). Concomitantly with (or rapidly upon) the 
association of β2-microglobulin with the HC (3), calreticulin (CRT) is incorporated (4). The resulting 
trimer (4) is inserted into a so-called precursor complex (5) that comprises the TAP transporter, 
tapasin, calnexin (CNX) and ERp57. This final fusion yields the mature peptide loading complex 
(6) and is (according to the standard model) believed to be accompanied by the release of 
calnexin.  
2000; Lindquist et al, 2001) together with the finding that heavy chains are already 
partially oxidized at this stage (Dick et al, 2004; Tector et al, 1995; Farmery et al, 
2000) makes it tempting to speculate that ERp57 is the oxidase, responsible for the 
formation of the respective disulfide bonds, although a contribution of other ER-
resident oxidases as e.g. PDI cannot be excluded. Consistent with this view disulfide-
linked dimers of free MHC class I heavy chains and ERp57 could be isolated from 
human cells (Lindquist et al, 2001) and rat cells expressing human HLA-B27 
(Antoniou et al, 2002). Full oxidation of MHC class I heavy chains, which is believed 
to precede their incorporation into the PLC (Dick et al, 2004) is a prerequisite for an 
MHC class I molecule to become peptide-receptive as is the association with β2-
microglobulin (Neefjes et al, 1993; Sugita et al, 1994). Binding of β2-microglobulin to 
the MHC class I heavy chain is accompanied by the subsequent release of calnexin 
and thereby dissociates the initial assembly complex (at least in human cells) (Sugita 
et al, 1994). Since ERp57 on its own has no peptide-binding activity (Ellgaard et al, 
2004) and is believed to be recruited to its substrate proteins solely through 
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interactions with the lectin chaperones it is plausible to assume that ERp57 is also 
released at this point. Rapidly upon (or concomitantly with) the binding of β2-
microglobulin, calreticulin associates with the assembled MHC class I molecule, 
which at this stage is likely to harbor monoglucosylated N-linked glycans (Wearsch et 
al, 2004; Radcliffe et al, 2002). Calreticulin recognizes MHC class I via one of its 
three exposed sugar trees (Harris et al, 2001). Consistently, treatment with 
castanospermine, a drug that inhibits the deglucosylation of N-linked glycans 
prevents the formation of a complex between MHC class I and the lectin chaperone 
in vivo (Sadasivan et al, 1996). In the past it had been postulated that calreticulin 
tethers ERp57 back into the assembling PLC (Harris et al, 2001). However, this view 
was challenged by the finding that the oxidoreductase co-precipitates at normal 
levels with TAP in calreticulin-deficient cells (Gao et al, 2002). So far the exact 
function that calreticulin exerts within the PLC has not been determined, although 
diverse roles as e.g. cooperative stabilization of the PLC, chaperoned peptide-
delivery from TAP to MHC class I or assisted folding of MHC class I have been 
proposed (Gao et al, 2002; Culina et al, 2004). One attractive hypothesis postulates 
that calreticulin tethers empty (or suboptimally loaded) MHC class I molecules that 
are about to escape the ER back into the PLC (Gao et al, 2002). Such a role in MHC 
class I retention is in keeping with the observation that cells deficient for calreticulin 
display accelerated export of unstable, peptide-receptive class I that largely 
dissociates during (or upon) the migration to the plasma membrane (Gao et al, 
2002). It is important to note that the selective retrieval of empty (or suboptimally 
loaded) MHC class I to the PLC would place calreticulin in the focus of a quality 
control pathway that ensures the egress from the ER of only highly stable MHC-
peptide-complexes. Indeed, this safeguard mechanism is the central function exerted 
by the PLC (Wright et al, 2004). However, the retention of MHC class I, which is (for 
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whatever reason) inappropriate for ER export, represents a rather passive 
contribution to the quality control of peptide loading. A more active role is believed to 
be played by another chaperone: the 48 kDa transmembrane glycoprotein tapasin. 
Prior to its incorporation into the PLC tapasin presumably forms a so-called precursor 
complex that additionally contains the peptide transporter TAP, ERp57 and calnexin 
(Diedrich et al, 2001). The biogenesis of this early complex is not yet well described. 
However, a recent report suggests that the assembled PLC finally results from the 
tapasin-mediated introduction of calreticulin-associated MHC class I into this 
precursor complex (Diedrich et al, 2001). It was stated that this last step in the 
assembly of the PLC leads to the release of calnexin (at least in human cells) 
(Diedrich et al, 2001), so that the PLC in the end consists of TAP, tapasin, 
calreticulin, ERp57 and MHC class I (Wright et al, 2004). Tapasin binds at the same 
time MHC class I molecules via its ER-luminal N-terminus (Bangia et al, 1999) and 
TAP via its C-terminal transmembrane domain (Raghuraman et al, 2002; Lehner et 
al, 1998; Tan et al, 2002), thereby acting as a bridge between peptide transporter 
(TAP) and peptide receptor (MHC class I) (Fig. 4). The transmembrane domains of 
both TAP subunits can bind tapasin independently from each other (Raghuraman et 
al, 2002). Thus, it was hypothesized that TAP has the potential to form a PLC via 
TAP1 and TAP2 in a symmetrical manner (Fig. 4). Soon after the discovery of 
tapasin it was noticed that cells that are deficient for this chaperone display 
substantially reduced (or complete loss of) MHC class I surface levels, albeit some 
allelic variation is observed (Garbi et al, 2000; Grandea et al, 1997; Ortmann et al, 
1997; Peh et al, 1998). This is a consequence of a series of events that all together 
have a negative impact on proper loading of MHC class I with optimal high affinity 
peptide ligands. First, tapasin is required for stabilization of TAP and is therefore 
needed to maintain high expression levels of the transporter (Garbi et al, 2003; 
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Lehner et al, 1998; Tan et al, 2002). Additionally, tapasin stimulates the binding of 
cytosolic peptides to TAP (Li et al, 2000). Thus, in its absence the overall amount of 
peptides being translocated into the ER is drastically reduced (Abele et al, 2004; 
Lehner et al, 1998; Li et al, 2000; Momburg et al, 2002). Second, by the above 
mentioned bridging function a close proximity between TAP and MHC class I is 
achieved, which may allow for a high local peptide concentration in the immediate 
vicinity of MHC class I (Abele et al, 2004). In this context, it is important to note that 
diminished peptide binding by MHC class I in a situation where tapasin is missing 
has been reported (Dick et al, 2002). It should additionally be mentioned that the 
close proximity between TAP and MHC class I may ensure that the latter is supplied 
with that specific pool of peptides that has most recently been generated in the 
cytosol. The benefit for the immune system could be that viral peptides would 
efficiently become accessible to class I as early as possible before the antigen 
processing machinery may be subverted by viral evasion strategies at a later time 
point during infection (Wright et al, 2004). Third, tapasin is similarly to calreticulin 
required for the retention of empty or suboptimally loaded class I molecules in the ER 
(Barnden et al, 2000; Schoenhals et al, 1999). Hence, the absence of tapasin results 
in a premature release into the secretory route of unstable MHC class I molecules, 
that later at the cell surface show a drastically increased tendency to acquire 
exogenously applied peptide (Barnden et al, 2000). Interestingly, one group observed 
accelerated egress from the ER of MHC class I also in human cells expressing a 
tapasin variant that fails to interact with TAP (Lehner et al, 1998), pointing towards a 
role for the TAP-tapasin interaction in the retention of class I. Although, these results 
are controversially discussed (Tan et al, 2002), they beautifully fit into a model where 
the PLC acts in the ER-membrane as an anchor that retains yet improperly loaded 
MHC class I until optimization of its peptide cargo has occurred. In line with this idea 
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TAP-associated MHC class I displays a dramatically decelerated lateral diffusion 
within the ER membrane when compared to free peptide-loaded molecules (Marguet 
et al, 1999). Furthermore, a mutant MHC class I molecule lacking both, tapasin- and 
calreticulin-interaction was reported to leave the ER loaded with TAP-dependent low-
affinity peptides at a highly accelerated rate (Lewis et al, 1996; Lewis et al, 1998; 
Paulsson et al, 2004; Peace-Brewer et al, 1996). Interestingly, an artificial retention 
of this MHC class I variant in the ER by transient application of the drug brefeldin A 
let to a significant improvement in the stability of MHC-peptide complexes (Lewis et 
al, 1998). This demonstrates that increasing the time that an MHC class I molecule 
spends in the ER as such has a significant positive effect on its stability and suggests 
that optimization of peptide cargo is time-dependent. Taken together, it is attractive to 
speculate that TAP-bound tapasin acts as a docking station in the PLC for calreticulin 
that functions in the recruitment of empty (or suboptimally loaded) MHC class I 
molecules for allowing them the acquisition of high affinity ligands. However, the 
major contribution of tapasin to the quality control of peptide loading does 
presumably not simply lie in the passive retention of suboptimally loaded MHC class I 
molecules in the ER. Rather, in the past years a role for tapasin as a peptide editor 
for MHC class I analogous to the function of the chaperone HLA-DM for MHC class II 
(Brocke et al, 2002) has been described and is despite one conflicting report (Zarling 
et al, 2003) widely accepted in the field (Howarth et al, 2004; Sesma et al, 2005; 
Williams et al, 2002). As a consequence of this peptide editing (or filtering) function 
exerted by tapasin highly stable MHC-peptide complexes are formed through 
selective loading of peptide ligands with low off-rates (Howarth et al, 2004; Sesma et 
al, 2005; Williams et al, 2002). Consistently, the peptide repertoire presented on the 
surface of tapasin-deficient cells is altered when compared to tapasin-proficient cells 
(Garbi et al, 2000; Howarth et al, 2004; Purcell et al, 2001; Zarling et al, 2003). 
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However, the corresponding mechanism is still not clear. A recent review proposes 
that tapasin deforms the peptide binding pocket of a bound MHC class I molecule in 
a way that some stabilizing contacts to the peptide cannot be formed (Wright et al, 
2004). Under such conditions, which disfavor peptide binding only high affinity 
ligands are thought to resist the dissociation from MHC class I. It should be noted 
that this effect may counterbalance the function of tapasin as a facilitator of class I 
peptide loading (see above) and that some variation with regard to the nature of the 
peptide ligands would be expected. Further elucidating the role of tapasin in the PLC, 
several independent studies have shown that tapasin is essential for the recruitment 
of ERp57 into the complex (Dick et al, 2002; Diedrich et al, 2001; Harris et al, 2001; 
Hughes et al, 1998; Tan et al, 2002) where both polypeptides are disulfide-linked with 
each another (Dick et al, 2002). The exact function that the oxidoreductase exerts 
within the PLC is not known yet. However, in cells expressing a tapasin variant that 
fails to recruit ERp57 PLC-associated MHC class I molecules were found to be 
partially reduced (Dick et al, 2002). Crystal structures of class I suggest that the 
disulfide-bridge in the α2-domain, which is located at the fringe of the peptide binding 
pocket may be rather exposed (and thereby vulnerable to reduction) in the absence 
of a peptide ligand (Dick et al, 2004). Therefore, ERp57 may passively shield this 
disulfide-bridge against reduction by glutathione as long as no (optimal) peptide is 
bound (Dick et al, 2004). Another model argues in a similar direction by proposing a 
more active role for ERp57 as an oxidase in the PLC that regenerates partially 
reduced MHC class I (Dick et al, 2002). ERp57 is further believed to act as a clamp 
between calreticulin and tapasin, thereby increasing the overall stability of the PLC 
by cooperative interactions (Wright et al, 2004). Moreover, a periodical resolution of 
the disulfide-bridge between ERp57 and tapasin was recently proposed to act as a 
timer for the release of loaded class I from the PLC (Wright et al, 2004). It was 
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speculated that when this bond is broken the cooperativity of the tapasin-calreticulin-
interaction would be disrupted with the consequence that the affinity of tapasin for 
MHC class I would decrease (Wright et al, 2004). At this stage a bound high affinity 
peptide could induce the closure of the peptide binding pocket and thereby displace 
tapasin from class I (Wright et al, 2004). Subsequently, the stably loaded MHC class 
I molecule could be deglucosylated followed by its release from calreticulin and the 
PLC (Wright et al, 2004). However, this model is yet speculative and remains to be 
proven. Another recent report presented evidence that the recruitment of ERp57 to 
the PLC is essential for the optimization of the peptide cargo loaded onto class I 
(Dick et al, 2002). Since ERp57 was reported to possess cysteine-protease activity 
(Urade et al, 1992) this enzyme may directly shape the MHC class I-associated 
peptide repertoire. However, another study could not validate a role for the 
oxidoreductase in peptide editing (Howarth et al, 2004). Nevertheless, ERp57 could 
play a role in the degradation of suboptimally loaded (or empty) MHC class I, thereby 
helping to selectively remove unstable molecules that otherwise would enter the 
secretory route. Class I molecules that (for whatever reason) cannot fold or acquire 
peptide properly are believed to become retrotranslocated into the cytosol, where 
they are deglycosylated and subsequently degraded by the proteasome (Hughes et 
al, 1997). Accordingly, inhibitors that interfere with the availability of peptides within 
the ER like lactacystin (proteasome inhibitor), ALLN (proteasome inhibitor) or ICP47 
(TAP inhibitor) induce (or drastically enhance) the transfer of class I back into the 
cytosol (Hughes et al, 1997), probably using the Sec61 channel (Pilon et al, 1997; 
Wiertz et al, 1996). The resolution of disulfide-bridges within such molecules is 
believed to precede their delivery to the cytosol (Tortorella et al, 1998) and may be a 
prerequisite for the complete unfolding of the protein prior to dislocation. Interestingly, 
ERp57 was found to possess reductase (in addition to disulfide isomerase and 
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oxidase) activity in vitro (Antoniou et al, 2002; Frickel et al, 2004). Partially folded 
MHC class I is a substrate for this reductase activity, whereas fully folded molecules 
are resistant (Antoniou et al, 2002). Although the oxidoreductase does not resolve 
disulfide bonds within suboptimally loaded MHC class I it acts on peptide-free 
molecules (Antoniou et al, 2002). Since no biological process works with 100% 
fidelity, even peptide-loading within the PLC would be expected to yield a small 
fraction of MHC class I molecules associated with low-affinity ligands. ERp57-
mediated reduction of this population after loss of their peptide cargo would prevent 
the resulting empty class I molecules from binding new peptide outside the PLC and 
its associated peptide-editing machinery. Regarding this, it is important to note that 
class I molecules that have dissociated from the PLC are probably deglucosylated 
(Van Leeuwen et al, 1996) and therefore unlikely to be a substrate for calreticulin-
mediated retention. Interestingly, loaded MHC class I molecules were reported to be 
retained in the ER for a while until export occurs (Marguet et al, 1999). This would 
provide time for such an additional quality control step. In this context it should be 
mentioned that calnexin was also reported to be involved in the degradation of 
glycoproteins. The lectin chaperone was shown to hand over terminally misfolded 
polypeptides to the acceptor EDEM prior to their retrotranslocation into the cytosol 
(Molinari et al, 2003; Oda et al, 2003; Sifers et al, 2003). EDEM is an ER stress-
inducible membrane protein with homology to α-mannosidase that specifically binds 
to mannose-N-acetylglucosamine Man8GlcNAc2 isomer B and has been implicated in 
the degradation of ER glycoproteins (Molinari et al, 2003; Oda et al, 2003; Sifers et 
al, 2003). Upon application of proteasome inhibitors a population of MHC class I was 
reported to redistribute into a subcellular compartment, closely associated with the 
ER that additionally contains high amounts of calnexin (Kamhi-Nesher et al, 2001). It 
was speculated that this compartment is involved in the degradation of misfolded 
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polypeptides (Kamhi-Nesher et al, 2001). The predicted role of ERp57 in the 
degradation of MHC class I molecules (Antoniou et al, 2002) makes it is tempting to 
speculate that the oxidoreductase will also localize to the same subregions within the 
ER. Taken together, it is likely that protein complexes that are associated with MHC 
class I assembly share a very similar composition with complexes that are involved in 
MHC class I degradation. Both would be predicted to contain calnexin and ERp57 
along with class I.  
Interestingly, the amount of PLC-bound ERp57 has been reported to be significantly 
diminished in the TAP-deficient cell lines .174 (Hughes et al, 1998) and T2 (Momburg 
et al, 2002) or LCL .220 cells expressing a tapasin variant that fails to associate with 
TAP (Tan et al, 2002). This shows that TAP is required in human cells for stable 
integration of ERp57 into the PLC and underscores the importance of cooperative 
interactions among PLC components for the structural integrity of the complex. 
Strikingly, the ability of tapasin to bind the peptide transporter was reported to be 
essential for optimal peptide loading onto MHC class I, but not for high class I surface 
levels (Lehner et al, 1998; Tan et al, 2002). This becomes evident by an abnormally 
high thermolability (Gao et al, 2004; Momburg et al, 2002; Tan et al, 2002; Williams 
et al, 2002) and reduced surface half-life of MHC class I molecules (Tan et al, 2002; 
Williams et al, 2002) in cells that express tapasin variants, which fail to interact with 
TAP. However, none of these studies rules out that the low TAP-steady state 
expression level (as a consequence of lacking transporter stabilization by tapasin 
(see above)) and therefore the low peptide translocation rate into the ER is the 
reason for the obvious defect in class I loading. Additionally, given that TAP 
contributes to the peptide editing process, it is not clear, whether the peptide 
transporter acts by recruiting ERp57 into the PLC, by cooperatively stabilizing the 
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PLC, by increasing the local peptide concentration for MHC class I or by other yet 
unknown mechanisms.  
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2. Description of the project 
Both TAP subunits, TAP1 and TAP2, efficiently associate with tapasin, MHC class I 
and the accessory chaperones of the PLC when expressed as isolated subunits 
(Antoniou et al, 2002b; Daumke et al, 2001; Raghuraman et al, 2002). From these 
studies it had been concluded that cells expressing only one or the other TAP chain 
can serve as a model system to analyze the protein composition and biogenesis of 
the PLC. Years ago, it had been postulated that the N-domains that precede the core 
TMD in both TAP subunits (see above) may act as docking modules for tapasin. This 
speculation founded on the observation that other ABC proteins as e.g. the 
sulfonurea receptor (SUR) use their N-terminal extensions to assemble with 
additional components into higher order complexes (Babenko et al, 2003; Chan et al, 
2003). Similarly, the cytosolic N-terminal domain preceding the core TMD in the ABC 
ion channel CFTR functionally interacts with the SNARE protein syntaxin 1A to 
regulate the chloride transport (Naren et al, 1998). Thus, to determine whether the N-
termini of the TAP chains play a role in the recruitment of tapasin, Koch and co-
workers had recently generated a truncation-variant of human TAP, lacking both N-
domains. The respective transporter was over-expressed in insect cells either alone 
or in combination with tapasin. These studies convincingly showed that the mutant 
transporter could efficiently bind and translocate peptides (Koch et al, 2004), 
demonstrating that the core TMD is sufficient to allow for the basic functions of the 
transporter. However, in contrast to wild-type TAP this transporter variant showed no 
detectable interaction with co-expressed tapasin (Koch et al, 2004), suggesting a key 
role for the N-domains in the organization of the PLC. In combination with the above 
mentioned finding that both TAP chains have an intrinsic capability to bind tapasin it 
was concluded that both N-domains simultaneously serve as tapasin docking sites. 
However, this conclusion is mainly based on the hypothesis that the interaction of 
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isolated TAP subunits with tapasin mirrors the respective interactions in the 
assembled transporter. This hypothesis has never been proven. Moreover, the weak 
point of the studies undertaken by Koch and co-workers is that they could not 
analyze the consequences of a possibly deficient PLC formation by N-terminal 
truncated TAP for MHC class I peptide loading, since they expressed the transporter 
variant in the absence of class I (Koch et al, 2004). Furthermore, effects of alterations 
within the PLC on the quality control of peptide loading can anyhow not be 
satisfactory analyzed in an insect cell system, where MHC class I-mediated antigen 
presentation does normally not take place. However, these questions are of high 
significance as in the absence of a proper working quality control instable MHC class 
I molecules are generated that tend to lose their weakly bound peptide cargo as they 
migrate along the secretory route. As a consequence they can end up at the cell 
surface as empty molecules (or even worse they might be reloaded by extracellular 
peptides and subsequently become recognized by CTLs). Yet, to elucidate the 
mechanisms that allow the formation of stable MHC class I molecules, presenting 
high affinity ligands is of fundamental importance to understand how an appropriate 
cellular immune response against intracellular pathogens is raised.  
Hence, to get insight into the function of the N-domains for the loading of MHC class I 
molecules with peptide ligands, N-terminally truncated TAP chains were expressed in 
the human TAP-deficient cell line T2 alone, in combination with the corresponding 
wild-type chain or as head-to-tail fusion proteins. The TAP variants were 
characterized in different functional assays for their ability to translocate class I 
ligands across the ER membrane. Moreover, the established cell lines were used to 
investigate, whether indeed both N-domains of the transporter simultaneously 
interact with tapasin (see above). Although recent reports have demonstrated that 
the insertion of TAP into the PLC is essential to allow MHC class I acquiring full 
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stability (Gao et al, 2004; Momburg et al, 2002; Tan et al, 2002; Williams et al, 2002) 
the underlying mechanism has not yet been elucidated. Moreover, all studies cited 
above analyzed cell lines expressing tapasin variants that fully fail to interact with 
TAP. Thus, it is impossible in the respective experimental systems to distinguish 
between effects caused by the loss of the TAP1-tapasin-interaction and effects due 
to the loss of the TAP2-tapasin interaction. In contrast, the cell lines established 
during this project provided a powerful means to experimentally separate tapasin-
binding in the two TAP chains. Thereby they allowed for the first time to investigate 
the molecular composition and function of PLCs wherein the transporter is 
incorporated solely via TAP1 or TAP2. Using the respective cell lines it became 
possible to examine, whether the bridging function of tapasin as such is sufficient to 
ensure the loading of optimal high affinity ligands as proposed by several groups. In 
this case bridging of the transporter to MHC class I by either TAP chain would be 
expected to equally improve the stability of the peptide-loaded molecules. 
Alternatively, the N-domains of TAP could play a more specific role beyond passively 
increasing the local peptide concentration for MHC class I during the loading 
process. To answer the question whether both N-domains are essential for the 
correct assembly of the PLC and its proper quality control function of MHC class I-
loading, the transient association of MHC class I molecules with the PLC, the kinetics 
of their maturation and finally the characteristics of their surface expression in the 
established cell lines was investigated. Furthermore, to probe for the stability of 
intracellular and surface exposed MHC class I molecules in the transfectants, their 
thermoresistance as well as the time-course of their decay from the cell surface was 
determined. The findings of these studies demonstrate the important role of the N-
domains of TAP for the structural and functional integrity of the PLC. Furthermore, 
they show that in a situation where the quality control function of the PLC fails, a 
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post-ER mechanism can rescue the surface expression of stable MHC class I 
molecules. Thus, the outcome of this work extends the knowledge on the biogenesis 
of the PLC and provides new insights into the early and late events of antigen 
presentation.   
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3. Abbreviations 
ADP   adenosine diphosphate 
ALLN   N-acetyl-leucyl-leucyl-norleucinal 
ATP   adenosine triphosphate 
BFA   brefeldin A 
BSA   bovine serum albumin 
CFTR   cystic fibrosis transmembrane conductance regulator  
CNX   calnexin 
CR   connector region 
CRT   calreticulin 
CTL   cytotoxic T-lymphocyte 
DMEM  Dulbecco´s modified Eagle´s medium  
DTT   1,4-dithio-DL-threitol 
ECL   enhanced chemiluminescence  
Endo H  endoglycosidase H 
FBS   fetal bovine serum 
FITC   fluorescein isothiocyanate  
HBV   hepatitis B virus 
HCMV  human cytomegalovirus 
HCV   hepatitis C virus 
HDA   hexa-D-arginine 
HEPES  N-[2-hydroxyethyl]-piperazine-N’-[ethanesulfonic acid] 
HIV   human immunodeficiency virus 
HKV   influenza A Hong Kong virus 
HLA   human leukocyte antigen 
HRP   horseradish peroxidase  
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HRSV   human respiratory syncytial virus 
HSAB   N-hydroxysulfosuccinimidyl-4-azidobenzoate 
HV68   γ-herpesvirus 68  
IMDM   Iscove´s modified Dulbecco´s medium  
MDR1   multidrug resistance transporter 1 
MFI   mean fluorescence intensity 
MHC   major histocompatibility  
NBD   nucleotide binding domain 
ND   N-domain 
NSF   N-ethylmaleimide-sensitive fusion protein 
PACE4  paired amino acid converting enzyme 4 
PAGE   polyacrylamide gel electrophoresis  
PBS   phosphate-buffered saline 
PC   proprotein convertase 
PLC   MHC class I peptide loading complex 
RPMI   Roswell Park Memorial Institute  
SARS   severe acute respiratory syndrome coronavirus  
SDS   sodium dodecyl sulphate 
SLO   streptolysin O 
SNARE  soluble NSF attachment protein receptor 
TAP   transporter associated with antigen processing 
TBS   Tris-buffered saline 
TGN   trans-Golgi network 
TMD   transmembrane domain 
Tris   tris-(hydroxymethyl)-aminomethane  
VZV   varicella-zoster virus
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4. Materials and Methods 
Molecular cloning, polymerase chain reaction (PCR), sodium dodecyl sulphate (SDS) 
polyacrylamide gel electrophoresis (PAGE) and Western blotting were carried out 
according to standard procedures (Ausubel et al, 1990; Coligan et al, 1995; 
Sambrook et al, 1989) using enzymes purchased from New England Biolabs, 
Promega and Amersham. SDS-PAGE was performed under reducing conditions if 
not otherwise indicated. Immunoblots were developed according to the ECL system 
(Amersham). Chemicals used were graded p.A. and purchased from Merck or Sigma 
unless otherwise specified. All solutions and culture media were prepared with 
ultrapure water derived from a combined reverse osmosis / ultrapure water system 
(Seral) equipped with UV and ultrafiltration. 
 
4.1 Cell lines and cell culture 
T2 is a human lymphoblastoid cell line deficient for the TAP subunits and expresses 
HLA-A2 and HLA-B5 MHC class I molecules (DeMars et al, 1984; Salter et al, 1985). 
Transfectants of T2 expressing rat wild-type TAPa (Momburg et al, 1992) or truncated 
variants of rat TAP1a and/or rat TAP2a were cultured in Iscove´s modified Dulbecco´s 
medium (IMDM) (Gibco/Invitrogen) supplemented with 10% fetal bovine serum (FBS) 
and 1 mg/ml G418 (PAA). CEM (Foley et al, 1965) and its calnexin-deficient 
derivative CEM-NKR (Howell et al, 1985) are T cell leukaemia cell lines that express 
the MHC class I alleles HLA-A1, HLA-A30, HLA-B21, HLA-Bw6 and HLA-Cw2 (Scott 
et al, 1995). Both were cultured in IMDM (Gibco/Invitrogen) supplemented with 10% 
FBS. T1 cells (Salter et al, 1985) were cultured in IMDM (Gibco/Invitrogen) 
supplemented with 10% FBS. The cervical carcinoma cell line HeLa (Scherer et al, 
1953) was grown in IMDM (Gibco/Invitrogen) supplemented with 10% FBS. The 
monocyte-derived cell line THP-1 (Tsuchiya et al, 1980) was cultured in Roswell Park 
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Memorial Institute (RPMI) + L-glutamine medium (Gibco/Invitrogen) supplemented 
with 10% FBS. Murine chemically transformed hepatocytes (TIB-75) (Patek et al, 
1978) and the human hepatoma cell line HepG2 (Knowles et al, 1980) were cultured 
in Dulbecco´s modified Eagle´s medium (DMEM) (Gibco/Invitrogen) supplemented 
with 10% FBS, 1 mM sodium pyruvate (Gibco/Invitrogen), 2 mM L-glutamine 
(Gibco/Invitrogen) and non-essential amino acids. All culture media contained 100 
U/ml penicillin (Gibco/Invitrogen) and 100 µg/ml streptomycin (Gibco/Invitrogen) to 
inhibit bacterial growth.  
 
4.2 Cloning and stable expression of TAP chain variants 
The vector pBluescript KS ΙΙ (+) (Stratagene) containing full-length rat TAP1a cDNA 
lacking the internal EcoRΙ-site (Deverson et al, 1990) or the full-length rat TAP2a 
cDNA (Powis et al, 1991) was used as template in the QuikChangeTM site directed 
mutagenesis procedure (Stratagene) to generate N-terminal truncated variants of 
TAP1 and TAP2. The complementary primers 5´-GCGCACGCTCGATGCCCTCCGG 
ACACAAGGGCGCTGG-3´ and 5´-CCAGCGCCCTTGTGTCCGGAGGGCATCGAGC 
GTGCGC-3´ were used to delete nucleotides 4-417 of rat TAP1a (position 1 is the A 
of the start codon) resulting in a TAP1 variant that lacks the residues 2-139 (1∆N). 
Primers 5´-CGCAGACCCCACCATGCCCGGGCAGGAGAATAACAGAGC-3´ and 5´-
GCTCTGTTATTCTCCTGCCCGGGCATGGTGGGGTCTGCG-3´ were used to delete 
nucleotides 4-384 from rat TAP2a resulting in a TAP2 variant that lacks the residues 
2-128 (2∆N). All primers were purchased from Invitrogen. From the resulting TAP 
constructs an EcoRΙ-fragment was cloned into the EcoRΙ-site of the expression 
vector pHßApr1neo (Gunning et al, 1987). The cDNA-constructs of TAP1 and TAP2 
were co-transfected in different combinations into TAP-negative T2 cells by 
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electroporation using a BioRad gene pulser (BioRad) at 270 V and 500 µF. 
Additionally, cell lines expressing single TAP chain variants were generated. For 
cloning of the two tandem transporters precursor plasmids were generated in a first 
step where the sequence encoding either wild-type TAP1 or 1∆N was followed by the 
sequence encoding 2∆N. Therefore, the pBluescript-derivative comprising 2∆N was 
digested with ScaΙ and Acc65Ι. The resulting 3269 bp-fragment was either ligated to 
the 4385 bp-fragment from a ScaΙ/BsrGΙ-digest of the pBluescript-derivative 
containing wild-type TAP1 or to the 3971 bp-fragment from a ScaΙ/BsrGΙ-digest of 
the pBluescript-derivative comprising 1∆N. Both plasmids were digested with AgeΙ 
and BbvCΙ resulting in a 7088 bp- or a 6674 bp-fragment, respectively. The 
fragments were ligated to the AgeΙ/BbvCΙ-fragments containing the linker region of 
murine MDR1b (Gros et al, 1986) (see below). The generated plasmids encoded 
tandem transporters containing (TD1/2∆N) or lacking (TD1∆N/2∆N) the N-domain in 
TAP1. The TAP-tandem variants were cloned as EcoRΙ-fragments into the 
expression vector pHβApr1neo (Gunning et al, 1987) and then transfected into T2 
cells. The murine MDR1b linker region was cloned by RT-PCR. Total RNA was 
collected from TIB-75 hepatocytes (Patek et al, 1978) using the RNeasy-Kit (Qiagen). 
Subsequently, mRNA was prepared using the Oligotex-Kit (Qiagen). An RT-PCR was 
performed using the SuperScript first-strand synthesis Kit (Invitrogen) in combination 
with the MDR1b-specific primer 5´-CCCCTACAATCCTTGAAAATACTATGGC-3´ at a 
concentration of 2 µM. The resulting cDNA served as a template in a standard PCR 
(the conditions used were identical to that chosen for the determination of the 
proprotein convertase expression in T2 cells (see below)) , in which primers 5´-
CCCCTACAATCCTTGAAAATACTATGGC-3´ and 5´-GGTGGTGTCATTGTGGAGC 
AAGG-3´ were used to amplify a fragment of 403 bp. This fragment was digested by 
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SacΙ and HinP1Ι yielding a 303 bp-fragment that was ligated with pBluescript KS ΙΙ 
(+) cleaved by SacΙ and AccΙ. The resulting vector served as a template in a 
standard Pfu-Polymerase-driven PCR using the TAP-MDR1b-chimeric primers 5´-
TGTTACCGGTCCATGGTGGAGGCTCTTGCGGCTCCTTCAGACCCAGGAAATAA 
TGCTTATGGATCCC-3´ and 5´-ATCCGGCTTGGACAGCCTCAGCAACCGCCAAAA 
GGAAACCAGAGGC-3´. Thereby a 252 bp-fragment was amplified, which was 
subsequently digested with AgeΙ and BbvCΙ. The resulting 227 bp-fragment encoded 
the last 12 residues of rat TAP1a followed by MDR1b-sequence 640-701 and the 
residues 140-141 of rat TAP2a. This AgeΙ/BbvCΙ-fragment was ligated with the 
AgeΙ/BbvCΙ-fragments that were derived from the tandem precursor plasmids (see 
above). All TAP constructs were fully sequenced from both directions. All cell lines 
expressing TAP single chains or heterodimeric TAP variants were subcloned. Cells 
expressing high MHC class I surface levels were enriched by magnetic activated cell 
sorting (MACS) using the MiniMACS-Separator (Miltenyi Biotec) in combination with 
the anti-MHC class I-antibody 4E and magnetically labelled rat-anti-mouse IgG2a+b 
(Miltenyi Biotec). Recovered cells were subcloned for a second time.   
 
4.3 Antibodies 
116/5 and D90 are polyclonal rabbit antisera recognizing the C-terminus of rat TAP2 
(Momburg et al, 1992) or rat TAP1 (Powis et al, 1991). 148.3 is a monoclonal 
antibody directed against the C-terminus of human TAP1 (Meyer et al, 1994). 3B10.7 
is a monoclonal rat anti-human MHC class I antibody binding the heavy chains of 
HLA-A and -B (Lutz et al, 1987). 4E is a β2m-dependent mouse monoclonal antibody 
that recognizes an epitope common to all assembled HLA-B molecules (Yang et al, 
1984; Trapani et al, 1989; Tector et al, 1995). w6/32 is a mouse monoclonal antibody 
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that recognizes β2m-associated HLA-A, HLA-B and HLA-C molecules (Barnstable et 
al, 1978). Anti-ER60 is a rabbit antiserum that binds the oxidoreductase ERp57 (Otsu 
et al, 1995). R.gp48N is a polyclonal rabbit antiserum that is specific for the N-
terminus of human tapasin (Sadasivan et al, 1996). SPA-600 and -865 are polyclonal 
rabbit antisera binding calreticulin or calnexin (StressGen). MP-1 and KP-1 are 
polyclonal antisera, directed against the N-terminus or the C-terminus of the 
proprotein convertase 7 (PC7), respectively (Van de Loo et al, 1997). Anti-furin is a 
polyclonal antiserum raised against the proprotein convertase furin (Leitlein et al, 
2001). MAC 256 is a rat-derived monoclonal antibody recognizing the ER retention 
motif KDEL (Napier et al, 1992). Alexa-488 labeled donkey-anti-rat IgG and Alexa-
546 labeled goat-anti-rabbit IgG were purchased from Molecular Probes. Fluorescein 
isothiocyanate (FITC)- and horseradish peroxidase (HRP)-conjugated antibodies 
were purchased from Dianova or Amersham.  
 
4.4 Immunoprecipitation and Western blot analysis 
1 x 107 cells were washed twice in PBS before lysis in PBS / 1% Triton-X-100 
(Sigma). In case that the intact PLC should be co-isolated lysis was performed in 
PBS / 1% digitonin (Wako) as this detergent is known to preserve the TAP-tapasin 
association. Postnuclear supernatants were subsequently applied for at least 16 
hours at 4 °C to the respective antibody linked to sepharose beads for allowing 
immunoadsorption to occur. Antibodies had been covalently coupled before either to 
cyanogen bromide-activated sepharose (Sigma) in case that anti-MHC class I 
antibodies 4E or 3B10.7 were used or protein A-sepharose (Amersham) in case that 
anti-TAP1 antibodies 148.3 or D90 or the anti-TAP2 antiserum 116/5 was used. The 
coupling procedure was performed according to the instructions of the manufacturer. 
After extensive washing of the precipitate with PBS / 1% Triton-X-100 or PBS / 0,1% 
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digitonin (depending on the detergent used for lysis) bound proteins were eluted in 
100 mM Tris / 0,5% SDS pH 9,0. In case that consecutive immunoprecipitation 
sequentially using the anti-TAP2 antiserum 116/5 followed by the monoclonal 
antibody 3B10.7 was performed, bound proteins were eluted from the 116/5-
sepharose by a 2 hour incubation at room temperature in the presence of 100 µM of 
a peptide corresponding to the C-terminus of rat TAP2 (EQDVYAHLVQQRLEA, in 
single letter amino acid code) (Momburg et al, 1992) diluted in PBS / 1% digitonin. 
Eluted samples were separated by SDS-PAGE under reducing conditions. In case 
that calreticulin should be detected later on, SDS-PAGE was performed under non-
reducing conditions. Separated proteins were transferred to a nitrocellulose 
membrane (Schleicher & Schuell) before blocking in PBS / 0,1% Tween20 / 5% dry 
milk powder for 16 hours at 4 °C. Specific polypeptides were decorated with the 
respective primary antibodies diluted in PBS / 10% FBS / 0,1% Tween20 followed by 
extensive washing using PBS / 0,1% Tween20. This was followed by incubation of 
the membrane with HRP-conjugated secondary antibody. Unspecifically bound 
antibody was removed by washing in PBS / 0,3% Tween20. Finally immunoblots 
were developed according to the ECL system (Amersham).   
 
4.5 Inhibition of proteasomal activity with ALLN  
T2 transfectants were incubated in the absence or presence of 250 µM ALLN 
(Calbiochem) for 4h at 37 °C. Subsequently, cells were lysed in PBS / 1% digitonin 
either immediately or after removal of the inhibitor by extensive washing followed by 
overnight incubation at 37 °C in inhibitor-free IMDM containing 10% FBS. TAP-
associated proteins were isolated using the TAP2-specific antibody 116/5. Where 
indicated, MHC class I-associated proteins were re-precipitated from the eluate. 
Isolated proteins were separated by SDS-PAGE and analyzed by Western blot.  
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4.6 Pulse-chase analysis 
Transfectants were starved for 2h in methionine/cysteine-free Roswell Park Memorial 
Institute (RPMI) medium. Then, [35S]methionine and [35S]cysteine (500 µCi 
Promix/ml, Amersham) was added for 45 min. The chase was initiated by the 
addition of medium containing a 10-fold excess of unlabelled methionine and 
cysteine. Equal numbers of cells were removed at various times of chase and 
washed in phosphate-buffered saline (PBS) before resuspension in lysis buffer (PBS 
containing 1% digitonin (Wako) or 1% Triton X-100 (Sigma)). Immunoprecipitations 
were performed from equivalent amounts of precleared lysates by using anti-TAP2 
antiserum (116/5) or anti-MHC class I antibody (4E). The samples were washed five 
times with lysis buffer and subsequently separated by SDS-PAGE under reducing 
conditions. The gels were stained with Coomassie brilliant blue (Roth) and dried. 
Fluorographs were obtained after different exposure times and scanned by 
microdensitometry using a Joyce-Loebl Chromoscan II (Joyce-Loebl).  
 
4.7 Determination of MHC class I thermostability in detergent extracts 
1 x 108 cells were washed twice with ice-cold PBS before lysis in PBS containing 1% 
NP-40 (Sigma) and protease inhibitor-cocktail (Roche). When indicated, lysates were 
pre-incubated for 1 hour with 20 µM of HLA-B5 binding peptide EBV-3C/881-9 
(QPRAPIRPI, in single letter amino acid code) (Hill et al, 1995) at 4°C. Subsequently, 
lysates were incubated for 30 min at 4°C (where suboptimally loaded or empty class I 
molecules are preserved) or at 37°C (where only stable class I molecules resist 
dissociation). Afterwards lysates were immunoprecipitated using the monoclonal anti-
MHC class I antibodies 4E (conformation-dependent) or 3B10.7 (conformation-
independent). Precipitates were analyzed by Western blot and the obtained signals 
were quantified by densitometric scanning. 
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4.8 Immunofluorescence 
5 x 106 cells were washed twice with PBS before fixation in PBS containing 3% 
paraformaldehyde for 15 minutes. Subsequently cells were extensively washed with 
PBS / 10 mM glycine before resuspension in PBS / 0,5 % BSA. Next, the cells were 
permeabilized in PBS containing 0,5 % BSA and 0,5 % saponin and additionally a 
combination of anti-TAP antibody (either D90 directed against TAP1 or 116/5 
directed against TAP2, both of rabbit origin) and anti-KDEL antibody (MAC 256, 
derived from rat) was applied. After 30 minutes incubation, cells were washed twice 
with PBS / 0,5 % BSA / 0,5 % saponin before addition of a combination of two 
secondary antibodies, namely Alexa 488-coupled anti-rat IgG and Alexa 546-coupled 
anti-rabbit IgG. Unspecifically bound antibody was removed by washing with PBS / 
0,5 % BSA / 0,5 % saponin. Subsequently, cells were resuspended in 20 µl mowiol 
and transferred to an object slide. Stained cells were analyzed using a Zeiss 
Axioplan II fluorescence microscope equipped with a cooled CCD camera (Quantix). 
 
4.9 Deglycosylation of MHC class I molecules with endoglycosidase H (EndoH) 
10 µl of a Triton X-100 lysate, corresponding to 1 x 105 cells was added to 20 µl 
EndoH-incubation buffer (50 mM trisodium citrate / 0,01% SDS / 0,1 M 2-
mercaptoethanol) and mildly vortexed for 30 minutes before addition of 7,5 mU 
endoglycosidase H (Roche). Digestion was performed at 37 °C for 16 hours and the 
glycosylation pattern of MHC class I molecules, which corresponds to the steady 
state distribution of MHC class I molecules between the ER and post-ER 
compartments was determined by Western blot, using the monoclonal antibody 
3B10.7. The relative intensity of the bands was quantified by densitometric scanning, 
using the Joyce-Loebl Chromoscan II densitometer (Joyce-Loebl). 
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4.10 Flow cytometry and determination of MHC class I thermostability in intact 
cells 
5 x 106 cells were washed twice in ice-cold DFN (PBS / 10% FBS / 0,9 mM 
CaCl2*2H2O / 0,5 mM MgCl2*6H2O / 0,01% NaN3) and subsequently stained with 
monoclonal HLA-B5-reactive antibody 4E diluted in DFN at a final concentration of 
100 µg/ml for 30 min at 4 °C. After four-fold washing with ice-cold DFN cells were 
incubated with secondary FITC-labelled anti-mouse IgG antibody for 30 min at 4 °C 
in the dark. After four-fold washing with ice-cold DFN 3 µl propidium iodide (Sigma) 
was added to stain permeabilized (dead) cells. Subsequently, HLA-B5 surface levels 
were determined using a FACScan flow cytometer (Becton-Dickinson). To investigate 
the heat-sensitivity of intracellular and surface MHC class I, transfectants were 
incubated for 10 min at 4, 40, 50 and 60°C. Thermostability of intracellular HLA-B5 
was analyzed by an experiment in which cells were treated with 0.5% 
paraformaldehyde for 15 min and washed with 10 mM glycine. Cells were 
permeabilized in PBS containing 0.5% saponin / 0.5% BSA. Simultaneously the 
monoclonal antibody 4E was applied for 30 min at room temperature. Before addition 
of FITC-coupled anti-mouse IgG unspecifically bound antibodies were removed by 
washing with PBS containing 0.5% saponin and 0.5% BSA. The thermostability of 
MHC class I molecules in CEM or CEM-NKR cells was examined in an analogous 
procedure with the exception that the monoclonal antibody w6/32 was used instead 
of the antibody 4E. To determine thermostability of surface HLA-B5, cells were 
directly immunostained with mAb 4E without fixation and permeabilization. The 
dependence of MHC class I presentation on endocytic recycling and endosomal 
processing was analyzed by an experiment in which cells were grown in IMDM 
containing 250 µM primaquine or 20 mM NH4Cl (Sigma) for 3 and 18h, respectively. 
To determine the surface-survival of HLA-B5 cells were incubated for 0h, 1h, 2h, 4h, 
 
4. Materials and Methods 39
12h or 15h in the presence of brefeldin A (BFA) (Sigma) at a final concentration of 10 
ng/µl. To analyse the involvement of proprotein convertases (PCs) in antigen 
presentation cells were washed with FBS-free IMDM followed by removal of surface 
MHC class I molecules by incubation with IMDM / 50 mM Na-citrate pH 3.0 for 3 min. 
After neutralizing the pH with 150 mM NaH2PO4, pH 10.5 recovery of surface MHC 
class I was allowed to occur. Therefore, the transfectants were washed and 
incubated for 14 h at 37°C in FBS-free IMDM with or without 10, 33 or 100 µM hexa-
D-arginine (HDA) (Calbiochem). 
 
4.11 Nucleotide-binding assay 
2 x 107 cells were washed twice with ice-cold Tris-buffered saline (TBS) (50 mM Tris / 
150 mM NaCl pH 7,4) comprising 5 mM MgCl2 followed by a short incubation in 10 
mM Tris pH 7,4 (hypotonic buffer) at 4 °C. Subsequently, the cells were 
homogenized and nuclei were removed by centrifugation. The postnuclear 
supernatants were subjected to ultracentrifugation for the isolation of 
endomembranes, which were lysed for 1 hour at 4 °C in TBS / 5 mM MgCl2 / 1% 
Triton-X-100.  Lysed membranes were again centrifuged and precipitated (insoluble) 
material was discarded. The supernatant was applied either to ATP- or ADP-agarose 
(both purchased from Sigma), which had been equilibrated according to the 
instructions of the manufacturer. After 1 hour incubation at 4 °C precipitated material 
was washed 5 times with TBS / 5 mM MgCl2 / 1% Triton X-100, eluted in SDS-
containing sample buffer and analyzed in Western blots probed for TAP1 or TAP2. 
 
4.12 Radioiodination of peptides 
15 nmol of peptide S5 (TVDNKTRYV, in single letter amino acid code) (Momburg et 
al, 1994) or S8 (TVDNKTRYR, in single letter amino acid code) (Deverson et al, 
 
4. Materials and Methods 40
1998) were suspended in 100 mM phosphate buffer pH 7,5 and subsequently mixed 
with 5 µl of a 74 MBq solution of the radioisotope 125I (Amersham). To radioiodinate 
tyrosine residues Chloramin T-solution (Sigma) was added. Hereafter, free iodine 
was removed using a Dowex ion exchange column (Supelco) and the labelled 
peptide was eluted in phosphate buffer pH 7,5. 
  
4.13 Peptide cross-linking 
2 x 106 cells were permeabilized for 15 min at 37 °C using streptolysin O (SLO) 
(Murex) at a concentration of 2 U / ml. After washing with ice-cold PBS cells were 
resuspended in peptide binding buffer (50 mM Tris / 1 mM CaCl2 / 5 mM Mg(OAc)2 / 
1 mM DTT (Sigma) / 0,1% dialyzed denatured BSA / protease inhibitor-cocktail 
(Roche) pH 7,5). Subsequently, 1 µM radioiodinated and HSAB-conjugated peptide 
S5 (TVDNKTRYV, in single letter amino acid code) (Momburg et al, 1994) or S8 
(TVDNKTRYR, in single letter amino acid code) (Deverson et al, 1998) was applied, 
followed by UV-mediated (254 nm) cross-linking of bound peptide to TAP for 5 min 
on ice. Hereafter, cells were lysed in PBS / 1% NP-40 (Sigma) and the postnuclear 
supernatants were subjected to immunoprecipitation using the anti-TAP2 antibody 
116/5. Precipitated proteins were separated by SDS-PAGE. The gels were stained 
with Coomassie brilliant blue (Roth), dried and subsequently analyzed by 
autoradiography.    
 
4.14 Peptide transport assay 
3,75 x 106 cells were permeabilized for 15 min at 37 °C using streptolysin O (SLO) 
(Murex) at a concentration of 2 U / ml. Following a short wash with ice-cold PBS cells 
were resuspended in peptide transport buffer (50 mM HEPES / 150 mM KOAc / 5 
mM Mg(OAc)2 / 250 mM D(+)-sucrose / 1 mM DTT / protease inhibitor-cocktail 
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(Roche) pH 7,5) in the presence of 10 mM ATP. Radioiodinated peptide S5 
(TVDNKTRYV, in single letter amino acid code) (Momburg et al, 1994) or S8 
(TVDNKTRYR, in single letter amino acid code) (Deverson et al, 1998) was added to 
a final concentration of 1,5 µM and subsequently the cells were incubated at 37 °C 
for 15 min to allow for the transport of the labelled peptide into the ER (, which is 
resistant to permeabilization by SLO). Hereafter, cells were lysed for 5 min at room 
temperature in ConcanavalinA (ConA)-binding buffer (20 mM Tris / 500 mM NaCl / 1 
mM CaCl2 / 1 mM Mn(ΙΙ)Cl2 / 0,1% Triton X100 / 0,1% NP-40 / protease inhibitor-
cocktail (Roche) pH 7,5). Postnuclear supernatants were applied to ConA-sepharose 
(Sigma) and binding of glycosylated (transported peptides) was allowed to occur for 1 
hour. Subsequently, the precipitates were washed 5 times with ConA-binding buffer 
and recovered radioactivity was quantitated by γ-counting. To directly compare the 
transport activities of wild-type TAP and truncated TAP variants the results of the 
transport assays were normalized for the expression levels of the different 
transporters. For quantitation of TAP steady-state levels, equivalent numbers of cells 
were lysed in 1% Triton X-100. Lysates were serially diluted 2-fold and separated by 
SDS-PAGE. After protein transfer onto nitrocellulose immunoblots were probed for 
TAP1 and TAP2. Quantification by densitometric scanning revealed very similar 
steady-state expression levels for TAPwt, 1-2∆N and 2-1∆N, but significantly lower 
expression levels for the tandem transporters TD1/2∆N and TD1∆N/2∆N.  
 
4.15 Determination of proprotein convertase expression by RT-PCR  
mRNA isolated from the T2 cell line as well as from the HepG2 cell line was kindly 
provided by Cemalettin Bekpen. Using this mRNA as a template the SuperScript first-
strand synthesis Kit (Invitrogen) in combination with 2 µM of a standard oligo(dT)-
 
4. Materials and Methods 42
primer (Invitrogen) was employed to perform RT-PCR. The resulting cDNA served as 
a template in a standard PCR to probe for the expression of individual proprotein 
convertases. All primer pairs were designed so that the amplified region is a part of 
all known isoforms of the respective gene and that it contains a large intron to 
exclude that a contamination by genomic DNA rather than cDNA served as a 
template for the PCR. The primer pair 5´-GCAACGGAGGCCAACACAACG-3´ and 
5´-GCGTTGAGGAGGCCGAAACCG-3´ was used to amplify a 424 bp-fragment from 
the cDNA, corresponding to the PC7 gene (Bruzzaniti et al, 1996). The primer pair 
5´-CTACGGCACCTCCGTGCAGCC-3´ and 5´-CTTGAATCCTGGGCCATTGCACG-
3´ was used to amplify a 769 bp-fragment from the cDNA, corresponding to the PC5 
gene (Mercure et al, 1996). The primer pair 5´-CAAACAATTCCTACTGCATCGTGG 
GC-3´ and 5´-CCGTTCACTTTCCAGTCGCTC GC-3´ was used to amplify a 628 bp-
fragment from the cDNA, corresponding to the PACE4 gene (Kiefer et al, 1991). The 
primer pair 5´-CGAGGATGACGGCAAGACAGTGG-3´ and 5´-CGGCGATTATAGGA 
CAGGGTGAGC-3´ was used to amplify a 726 bp-fragment from the cDNA, 
corresponding to the furin gene (Roebroek et al, 1986). The DNA was amplified 
under the following conditions: 94 °C for 2 min; 39 cycles of 94 °C for 30s, 65 °C for 
30s and 72 °C for 1 min; and a final extension at 72 °C for 15 min. The PCR products 
were analyzed on a 2% agarose gel. 
 
4.16 Examination of proprotein convertase regulation by interferons  
The cell lines T2, HeLa or THP-1 were treated for 24 hours with 200 U/ml interferon-γ 
(Peprotech) or 2000 U/ml interferon-β (PBL Biomedical Laboratories) before mRNA 
was prepared by the sequential use of the RNeasy-Kit (Qiagen) (for isolation of total 
RNA) and the Oligotex-Kit (Qiagen) (for isolation of mRNA). The resulting mRNA, 
which was kindly provided by C. Bekpen served as a template for cDNA synthesis by 
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RT-PCR using the SuperScript first-strand synthesis Kit (Invitrogen) in combination 
with 2 µM of a standard oligo(dT)-primer (Invitrogen). This cDNA was used as a 
template in a standard PCR to probe for the expression of the indicated genes. The 
primer pair 5´-CGAGGATGACGGCAAGACAGTGG-3´ and 5´-CGGCGATTATAGGA 
CAGGGTGAGC-3´ was used to amplify a 726 bp-fragment from the cDNA, 
corresponding to the furin gene (Roebroek et al, 1986). The primer pair 5´-GCAACG 
GAGGCCAACACAACG-3´ and 5´-GCGTTGAGGAGGCCGAAACCG-3´ was used to 
amplify a 424 bp-fragment from the cDNA, corresponding to the PC7 gene 
(Bruzzaniti et al, 1996). The primer pair 5´-CAAACAATTCCTACTGCATCGTGGGC-
3´ and 5´-CCGTTCACTTTCCAGTCGCTCGC-3´ was used to amplify a 628 bp-
fragment from the cDNA, corresponding to the PACE4 gene (Kiefer et al, 1991). The 
primer pair 5´-CTGAGCCTGTCCGAAGCCCTGC-3´ and 5´-GGACTTGGCGGTTCT 
GTGGAGG-3´ was used to amplify a 645 bp-fragment from the cDNA corresponding 
to the MxA gene (Aebi et al, 1989). The primer pair 5´-ATGACAACTTTGGTATCG 
TGGAAGG-3´ and 5´-GAAATGAGCTTGACAAAGTGGTCGT-3´ was used to amplify 
a 442 bp-fragment from the cDNA corresponding to the GAPDH gene (Hanauer et al, 
1984). The primer pair 5´-ATCTGGATGTGGTGTGTGCC-3´ and 5´-CTTGTAGTTTC 
TCGAGCTGG-3´ was used to amplify a 532 bp-fragment from the cDNA 
corresponding to the hGBP1 gene (Cheng et al, 1991). PCR was performed as 
described in the section above with modifications on the cycle number and the 
hybridization temperature. These were 25 cycles with a hybridization temperature of 
60 °C in the case that fragments corresponding to GAPDH, hGBP1 or MxA were 
amplified and 31 cycles with a hybridization temperature of 65 °C in the case that 
fragments corresponding to furin, PC7 or PACE4 were amplified. The PCR products 
were analyzed on a 2% agarose gel.  
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4.17 Preparation of microsomes from T2 cells by sucrose gradient fractionation 
1 x 108 cells were incubated in ice-cold 10 mM Tris pH 7,5 (hypotonic buffer) for 10 
min. Hereafter, the cells were homogenized and the nuclei were removed by 
centrifugation at 1600g and 4 °C. 0,33 vol 1,3 M sucrose buffer (20 mM HEPES pH 
7,5 / 25 mM CH3COOK / 5 mM (CH3COO)2Mg*4H2O / 1 mM DTT / protease inhibitor-
cocktail (Roche)) were added to the supernatant, which was again centrifuged at 
1600g and 4 °C. Following this, the postnuclear supernatant was subjected to 
ultracentrifugation at 100000g and 4 °C to isolate endomembranes, which were 
subsequently resuspended in 800 µl 0,25 M sucrose buffer. Next, 7 vol 2,5 M 
sucrose buffer were added and the solution was mixed for 1 hour at 4 °C. Hereafter, 
the membrane suspension was overlaid with 3 ml 2 M and 3 ml 1,3 M sucrose buffer. 
Finally, 800 µl 0,25 M sucrose were loaded onto the top of the gradient. To 
fractionate the membranes the sucrose gradient was centrifuged for 16 h at 4 °C 
(25500 rpm / SW41Ti-rotor / Beckman). The microsomes were subsequently 
collected at the interface between the1,3 M and 2 M sucrose buffer. After the addition 
of 1 vol 20 mM HEPES buffer (20 mM HEPES pH 7,5 / 25 mM CH3COOK / 5 mM 
(CH3COO)2Mg*4H2O / 1 mM DTT / protease inhibitor-cocktail (Roche)) the 
microsomal suspension was centrifuged at 100000g and 4 °C, resuspended in 400 µl 
membrane buffer (50 mM HEPES pH 7,5 / 250 mM sucrose / 1 mM DTT / protease 
inhibitor-cocktail (Roche)) and homogenized. Subsequently, 10 vol high salt buffer 
(50 mM HEPES pH 7,5 / 250 mM sucrose / 1 M KCl / 10 mM MgCl2*6H2O / 1 mM 
DTT / protease inhibitor-cocktail (Roche)) were added and the suspension was again 
centrifuged at 100000g and 4 °C. Following this, the microsomal pellet was washed 
with 1 ml high salt buffer and afterwards resuspended in membrane buffer at a final 
concentration of 1 equivalent/µl. Subsequently, the microsomes were again 
homogenized, snap frozen in liquid nitrogen and stored at -80 °C. 
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4.18 In vitro translation  
The TNT SP6 Quick Coupled Transcription/Translation System (Promega) was used 
to in vitro-express TAP2 variants in microsomal membranes. The pSP64 vector 
(Promega) containing wild-type TAP2 (pSP64-TAP2) was kindly provided by K. 
Keusekotten. A pSP64-derivative encoding 2∆N was generated by site directed 
mutagenesis using the QuikChangeTM protocol (Stratagene) in combination with the 
primer pair 5´-CGCAGACCCCACCATGGCGCCCGGGCAGG-3´ and 5´-CCTGCCC 
GGGCGCCATGGTGGGGTCTGCG-3´ and pSP64-TAP2 as a template. For in vitro-
expression 20 µl of microsomes (1 equivalent/µl) were pre-incubated with 0,5 µl 
RNasin-ribonuclease inhibitor (40U/µl) (Promega) in a first step. Furthermore, also 5 
µl plasmid DNA (500 ng/µl), encoding either TAP2 or 2∆N were pre-incubated with 
0,5 µl RNasin-ribonuclease inhibitor (40U/µl) (Promega). Subsequently, 40 µl of the 
TNT Quick Master Mix (Promega), 3 equivalents of microsomes, 500 ng plasmid 
DNA, 2 µl Diethylpyrocarbonate (DEPC)-H2O were incubated at 30 °C for 90 min in 
the presence of 80 µM methionine (Promega) in a final volume of 50 µl. 
 
4.19 Immunodepletion 
Following the in vitro-translation of mutant or wild-type TAP2 chains into microsomes 
derived from T2 transfectants, the membranes were collected by centrifugation at 
100000g and 4 °C and washed twice with PBS. Subsequently, the microsomes were 
solubilized in PBS / 1% digitonin (Wako). The newly synthesized TAP2 chains were 
removed from the resulting lysate in two successive rounds of immunodepletion 
using protein A-sepharose-conjugated anti-TAP2 antibodies (116/5). To control for 
the specificity of the immunodepletion microsomal lysates were incubated with free 
protein A-sepharose (Amersham) in parallel. To examine the heterodimerization of 
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the TAP subunits, the depleted lysates were analyzed in Western blots probed for 
TAP1 and TAP2.  
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5. Results 
5.1 ER-export and surface expression of MHC class I does not depend on the 
number or position of tapasin-docking sites in TAP 
To investigate the function of the N-domains in TAP for MHC class I processing, N-
terminally truncated variants of both rat TAPa subunits were constructed (see section 
4.2). The resulting mutant TAP chains, lacking the residues 2-139 in rat TAP1a or the 
residues 2-128 in rat TAP2a were named 1∆N or 2∆N, respectively (Fig. 5A). Both 
TAP chain variants were stably co-transfected or transfected in combination with the 
corresponding wild-type chain into the TAP-negative human cell line T2. Transporters 
containing wild-type TAP1 and 2∆N were termed 1-2∆N while transporters consisting 
of wild-type TAP2 and 1∆N were named 2-1∆N. Surprisingly, transfectants co-
expressing 1∆N and 2∆N could not be established, although more than 100 different 
clones from four independent transfection experiments were analyzed (data not 
Fig. 5 Expression of TAP variants lacking the N-domain in TAP1 or TAP2 
A) Schematic diagrams of wild-type TAP subunits, 1∆N and 2∆N. N-domains (ND), core 
transmembrane domains (core TMD), transmembrane segments and nucleotide binding domains 
(NBD) are indicated. Topology prediction of the TMDs was performed with TopPred II (Claros et al, 
1994). The regions corresponding to the tapasin-docking sites (Koch et al, 2004) are indicated. B)
Expression of 1-2∆N and 2-1∆N. Cell lysates were analyzed in Western blots probed for TAP1 or 
TAP2. TAP1 (black) and TAP2 (red) are shown as pictograms.  
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shown). This suggests that stable expression of a heterodimeric transporter variant 
lacking both N-domains is either harmful to the transfected T2 cell and/or that the 
TAP variant is structurally unstable and rapidly degraded. Nevertheless, Fig. 5B 
shows that 1-2∆N and 2-1∆N were expressed at levels comparable to that of the 
wild-type transporter. To functionally characterize 1-2∆N and 2-1∆N, the peptide-
binding behaviour of the two TAP variants was determined in a first step (Fig. 6A). 
 
Therefore, photolabeling experiments were carried out using the radioiodinated, UV-
cross-linkable model peptide S8 (TVDNKTRYR, in single letter amino acid code) 
(Deverson et al, 1998). Similar to wild-type TAP, 1-2∆N and 2-1∆N showed peptide-
cross-linking to both transporter subunits (Fig. 6A) suggesting normal substrate 
uptake by the truncated TAP variants. Next, the peptide translocation activity of 1-
2∆N and 2-1∆N was measured (Fig. 6B) using the model peptides S5 (TVDNKTRYV, 
in single letter amino acid code) (Momburg et al, 1994) or S8 (TVDNKTRYR, in single 
Fig. 6 Peptide-binding and transport activity of TAP truncation variants 
A) Peptide-binding of TAPwt, 1-2∆N and 2-1∆N. Permeabilized cells were incubated with 
radiolabeled and HSAB-conjugated peptide S8 (TVDNKTRYR). After UV-cross-linking and 
membrane lysis, TAP was immunoisolated with αTAP2 antiserum. Asterisks indicate unidentified 
cross-link products. B) Peptide transport activity. Cells were permeabilized and incubated with 
radiolabeled peptides S5 (TVDNKTRYV) or S8 (TVDNKTRYR) in the presence of ATP. The 
transport activity measured for 1-2∆N and 2-1∆N is expressed as percentage of the transport 
activity (quantified by γ-counting) obtained for TAPwt. 
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letter amino acid code) (Deverson et al, 1998). Consistent with the previous 
observation that the N-domains are not required for the transport function of TAP 
(Koch et al, 2004), both variants showed peptide-translocation-activities within the 
range of the wild-type transporter (Fig. 6B).  
Based on biochemical and structural data regarding the TAP-related ABC-
transporters MDR1 (Loo et al, 2004) and MsbA (Chang et al, 2001) it is plausible to 
speculate that the N-domains of TAP1 and TAP2 point in the heterodimeric 
transporter to opposite sides of the paired core TMDs (Fig. 2B) and act as two 
autonomous tapasin-docking sites for the transient interaction with MHC class I 
molecules. To investigate this, the ability of the truncated transporter variants to 
interact with tapasin and MHC class I was determined. Therefore, TAP or MHC class 
I molecules were immunoisolated from digitonin lysates of the cell lines T2(TAPwt), 
T2(1-2∆N) or T2(2-1∆N). Co-isolated proteins were subsequently analyzed by 
Western blot (Fig. 7A and Fig. 16). Clearly, both truncated transporter variants 
retained the ability to form complexes with tapasin and MHC class I. However, the 
anti-TAP immunoprecipitations revealed that the tapasin-interaction is reduced in the 
truncated TAP variants by approx. 50% when compared to the wild-type transporter, 
indicating that the latter binds tapasin via both N-domains. In contrast, the amounts 
of MHC class I co-precipitated with TAP were almost identical for the different 
transporter variants, indicating that the MHC class I-interaction is comparable among 
TAPwt, 1-2∆N and 2-1∆N. In accordance with this, pulse-chase experiments (Fig. 
7B) revealed that the half-life of interaction between newly synthesized MHC class I 
and the TAP-containing PLC is identical (approx. 100 min), irrespective whether the 
latter comprises TAPwt, 1-2∆N or 2-1∆N. Thus, despite reduced tapasin-binding, the 
PLCs formed by 1-2∆N and 2-1∆N show a normal transient interaction with peptide-
receptive MHC class I molecules. 
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Fig. 7 Functional characterization of PLCs that comprise TAP variants, which lack the N-
domain in TAP1 or TAP2. 
A) TAP/tapasin-interaction. Digitonin lysates of transfectants expressing truncated or wild-type 
TAPs were subjected to immunoprecipitation using the αTAP2 antiserum 116/5 or the monoclonal 
αMHC class I antibody 3B10.7. Precipitates were analyzed in Western blots probed for TAP1, 
TAP2, tapasin or MHC class I heavy chains. TAP1 (black) and TAP2 (red) are shown as 
pictograms. B) Kinetics of TAP-MHC class I interaction in different transfectants. Cells were pulse-
labeled for 60 min. and chased for the indicated time points. Lysates from equal numbers of cells 
were immunoprecipitated with αTAP2 antiserum and resolved by SDS-PAGE. Quantification of the 
co-isolated MHC class I signals was performed by densitometric scanning of the fluorographs. The 
amount of TAP-associated MHC class I isolated at each time point is expressed as percentage of 
the respective amounts detected directly after the pulse.  
In further approaches the intracellular processing (Fig. 8A), the kinetics of transport 
to the cell surface (Fig. 8B) and the steady-state surface expression (Fig. 8C) of 
MHC class I in the different transfectants was analyzed. Endoglycosidase H (endo 
H)-assays carried out using cell extracts from T2(TAPwt), T2(1-2∆N) and T2(2-1∆N) 
revealed that under steady-state conditions about 80% of MHC class I is present in 
post-ER compartments whereas in non-transfected T2 cells more than 80% of MHC 
class I is retained in the ER (Fig. 8A). In accordance with this, the recovery of HLA-
B5 surface levels after removal of extracellularly exposed MHC class I molecules 
through a short application of acidic buffer was similar in cell lines expressing TAPwt, 
1-2∆N and 2-1∆N (Fig. 8B). Consequently, the steady-state surface HLA-B5 levels in 
the transfectants T2(1-2∆N) and T2(2-1∆N) were determined to be almost identical to 
that observed in the cell line T2(TAPwt) (Fig. 8C).  
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Fig. 8 Intracellular maturation and surface expression of MHC class I in cells expressing 1-
2∆N and 2-1∆N 
A) Intracellular maturation of MHC class I. Cell lysates were incubated with endoglycosidase H 
and analyzed by Western blot using the monoclonal antibody 3B10.7 (bottom). The relative 
intensity of the MHC class I signals quantified by densitometric scanning is shown as bar graphs 
(top). B) Surface recovery of MHC class I. Assembled MHC class I molecules were removed from 
the surface of T2 transfectants by a short application of acidic buffer. After neutralization of the pH 
cells were grown at 37°C for the indicated time before the levels of surface-HLA-B5 were 
determined by flow cytometry using the monoclonal antibody 4E followed by FITC-labeled 
secondary antibody. C) MHC class I surface expression. Cells were incubated with monoclonal 
antibody 4E followed by FITC-labeled secondary antibody and surface expression of HLA-B5 was 
subsequently determined by flow cytometry (filled histograms). Background staining was analyzed 
by incubating with secondary antibody alone (non-filled histograms). 
Thus, neither the N-domain of TAP1 nor the N-domain of TAP2 is required for ER-
export or surface presentation of MHC class I molecules. Furthermore, the above 
mentioned data provides evidence that wild-type TAP, 1-2∆N and 2-1∆N, despite 
differences in the tapasin-binding behaviour do not quantitatively differ in their 
transient recruitment of MHC class I for peptide-loading. 
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5.2 Head-to-tail-fusion of TAP chains allows stable expression of transporters 
lacking the N-domains in both subunits 
Despite substantial efforts, a T2-transfectant stably co-expressing 1∆N and 2∆N 
could not be generated (see above). One possible explanation for this could be that a 
TAP transporter, which lacks both N-domains is hampered in its biogenesis. 
Misassembly of truncated TAP chains could lead to aggregation of the transporter 
and finally the accumulation of cell-toxic aggregates in the cell. Thus, to get an idea 
whether the complex assembly of 1∆N with 2∆N is impaired, an immunoprecipitation-
based assay was performed, which determines the efficiency of TAP complex 
formation by co-depletion of TAP1 with TAP2 chains (K. Keusekotten, R. M. 
Leonhardt, S. Ehses and M. R. Knittler, manuscript in preparation). By an in vitro-
expression system, it was recently demonstrated that stable and functional 
biogenesis of TAPwt requires the assembly of pre-existing TAP1 with newly 
synthesized TAP2, but not vice versa (K. Keusekotten, R. M. Leonhardt, S. Ehses 
and M. R. Knittler, manuscript in preparation). Therefore, either 2∆N or TAP2 was in 
vitro-translated in the presence of purified microsomes that already contained 1∆N or 
TAP1 (Fig. 9A). Following the in vitro-translation, the microsomes were lysed and the 
newly synthesized TAP2 subunits were removed in two sequential rounds of 
immunodepletion with the anti-TAP2 antiserum 116/5. To control for the efficiency of 
in vivo-complex assembly microsomal lysates from T2(TAPwt) cells were also 
subjected to immunodepletion. As shown in Fig. 9A the TAP1 chain was 
quantitatively removed with anti-TAP2 antibodies from solubilized membranes 
containing wild-type TAP, irrespective whether the TAP2 chain of the transporter had 
been synthesized in vivo (lane 6) or in vitro (lane 4). This suggests efficient 
dimerization of TAP1 and TAP2 in both cases. In contrast, the 1∆N chain displayed a 
strongly diminished co-depletion with the 2∆N chain, indicating that the assembly of 
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Fig. 9 Assembly of truncated TAP chains and expression of TAP tandem variants  
A) Complex assembly of in vitro expressed TAP chains. Microsomes derived from the indicated in 
vitro-translation experiments were lysed and immunodepleted with protein A-sepharose-
conjugated anti-TAP2 antibodies (αTAP2) or (as a control) with free protein A-sepharose (PA). 
Subsequently, the microsomal lysates were separated by SDS-PAGE and analyzed in Western 
blots simultaneously stained with antisera directed against TAP1 and TAP2. TAP1 (black) and 
TAP2 (red) are shown as pictograms. B) Schematic diagrams of TAP tandem variants. N-domains 
(ND), core transmembrane domains (core TMD), transmembrane segments, nucleotide binding 
domains (NBD) and the connector region of MDR1b (CR) are indicated. C) Expression of TAP 
tandem variants. Cell lysates were analyzed by Western blot using αTAP2 antiserum 116/5. 
Tandem TAPs are shown as pictograms. 
TD1∆N/2∆N 
TD1/2∆N 
A 
B C 
the two truncated TAP chains is substantially impaired (Fig. 9A, lane 2). It cannot be 
excluded at present that even the observed low degree of assembly in the latter case 
reflects the formation of microaggregates rather than functional heterodimers. 
Nevertheless, the in vivo-data (Fig. 7A) shows that neither 1∆N nor 2∆N has a 
general defect in complex assembly. Thus, it was speculated that a head-to-tail 
fusion of both truncated TAP chains to a single gene might circumvent the observed 
expression problems and allow for the generation of a TAP variant lacking both N-
domains in T2 cells. The order of TMDs and NBDs within such a gene would 
 
5. Results 54
resemble the genetic structure of so-called tandem ABC transporters, which encode 
the four characteristic domains of this transporter family (two TMDs and two NBDs) 
on one chain. In particular, a 1∆N-2∆N fusion protein would resemble the TAP-
related tandem multidrug resistance transporter 1 (MDR1) (Gros et al, 1986) as this 
transporter contains only the conserved six α-helices of the core TMD of ABC 
transporters, whereas any homologous sequence corresponding to the N-domains of 
TAP is lacking (Seigneuret et al, 2003). However, in MDR1 (as generally in tandem 
transporters) a flexible connector region of approx. 60 amino acids joins the two 
homologous halves of the protein (Hrycyna et al, 1998). The presence of this 
connector region was shown to be essential for transport function of MDR1 as its 
deletion results in an ATP-hydrolysis-deficient and transport-inactive protein (Hrycyna 
et al, 1998).   
Thus, a TAP-tandem-construct was generated, in which the cDNAs of 1∆N and 2∆N 
were linked by the connector region of murine MDR1b (Fig. 9B, lower panel; see 
section 4.2) (Gros et al, 1986). In addition, a second TAP-fusion construct was made 
containing wild-type TAP1 instead of 1∆N (Fig. 9B upper panel; see section 4.2). The 
resulting tandem constructs (named TD1∆N/2∆N and TD1/2∆N) were transfected into 
T2 cells and analyzed for steady-state expression by Western blot. Fig. 9C shows 
that both, TD1∆N/2∆N and TD1/2∆N were stably expressed in the transfectants.  
Next, the subcellular distribution of the two tandem TAP variants was analyzed by 
immunofluorescence. Fig. 10A shows that comparable to TAPwt both transporters 
co-localized with KDEL-containing polypeptides in the endoplasmic reticulum. For 
functional characterisation of TD1/2∆N or TD1∆N/2∆N peptide-binding (Fig. 10B) and 
translocation (Fig. 10C) were analyzed by the standard methods described above. 
Both tandem variants displayed detectable peptide-cross-linking suggesting that 
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specific antibodies and the co-isolated polypeptides were analyzed by Western blot 
(Fig. 11A). In line with the findings on TAP variant 1-2∆N (Fig. 7A and Fig. 16), the 
related tandem transporter TD1/2∆N retained the capacity to interact with tapasin 
and MHC class I whereas TD1∆N/2∆N, which lacks both N-terminal tapasin binding 
Fig. 11 PLC formation and functional characterization of tandem TAPs  
(A) TAP/tapasin-interaction. Digitonin lysates of transfectants expressing tandem TAP variants 
were subjected to immunoprecipitation using the αTAP2 antiserum 116/5 or the monoclonal 
αMHC class I antibody 3B10.7. Precipitates were analyzed in Western blots probed for TAP2, 
tapasin or MHC class I heavy chains. Tandem TAPs are shown as pictograms. (B) Intracellular 
maturation of MHC class I. Cell lysates were incubated with endoglycosidase H and analyzed by 
Western blot using the monoclonal antibody 3B10.7 (bottom). The relative intensity of the MHC 
class I signals quantified by densitometric scanning is shown as bar graphs (top). C) MHC class I 
surface expression. Cells were incubated with monoclonal antibody 4E followed by FITC-labeled 
secondary antibody and surface expression of HLA-B5 was subsequently determined by flow 
cytometry (filled histograms). Background staining was analyzed by incubating with secondary 
antibody alone (non-filled histograms). 
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sites, is completely excluded from the PLC (Fig. 11A). Next, the capability of 
TD1/2∆N and TD1∆N/2∆N to deliver peptide substrates for the loading onto MHC 
class I molecules was investigated. Since the expression levels of the functional 
tandem transporters were lower than the expression levels of wild-type TAP (Fig. 
9C), the cell lines T2(TD1/2∆N) and T2(TD1∆N/2∆N) displayed only a partial 
restoration of intracellular processing (Fig. 11B) and surface expression (Fig. 11C) of 
MHC class I. However, it is interesting to note that despite the differences in the 
tapasin/MHC class I recruitment by the two tandem transporters, the cell lines 
expressing TD1/2∆N and TD1∆N/2∆N showed very similar steady-state distributions 
of ER and post-ER MHC class I (Fig. 11B) and comparable amounts of surface HLA-
B5 (Fig. 11C). This implies that under conditions, in which physical interaction 
between TAP and tapasin is impaired, newly synthesized MHC class I molecules can 
take alternative routes of peptide-loading outside the TAP-associated PLC as long as 
suitable peptides are delivered by a functional transporter. 
 
5.3 Assembled and non-assembled TAP1 chains use different TMD-subregions 
for tapasin binding 
Comparison of the experiments on the tandem transporters and the heterodimeric 
variants suggests that both N-domains of TAP serve as functional interaction sites for 
tapasin and MHC class I molecules. However, the two TAP subunits are known to 
bind the components of the PLC independently from each other (Antoniou et al, 
2002b; Daumke et al, 2001; Newitt et al., 1999; Raghuraman et al, 2002). Thus, the 
question arises whether the interaction between tapasin and the N-domains depends 
on the heterodimerization of TAP1 and TAP2 or reflects an intrinsic property of the 
two TAP subunits. To address this question, 1∆N and 2∆N were stably transfected 
into T2 cells as single TAP chains. Analysis of the steady-state expression levels by 
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Western blot revealed that both variants were expressed at levels comparable to that 
of the corresponding wild-type TAP subunits (Fig. 12A). Both chains retained the 
normal nucleotide binding behaviour of the wild-type TAP subunits (Alberts et al, 
2001; Ehses et al, 2005) as the TAP1-variant bound both ATP and ADP whereas the 
TAP2-variant associated solely with ADP (Fig. 12B).   
 
Fig. 12 Expression, nucleotide binding and PLC formation of N-terminally truncated TAP 
subunits  
(A) Expression of N-terminally truncated TAP chains. Cell lysates were analyzed in Western blots 
probed for TAP1 or TAP2. TAP1 (black) and TAP2 (red) are shown as pictograms. (B) Nucleotide 
binding properties of single expressed TAP subunits. Membrane fractions of T2 transfections were 
lysed before incubation with different nucleotide-agaroses. Bound proteins were eluted with SDS-
containing sample buffer and analyzed in Western blots probed for TAP1 and TAP2. (C)
TAP/tapasin-interaction. Digitonin lysates of transfectants expressing N-terminally truncated TAP 
subunits were subjected to immunoprecipitation using the αTAP1 antiserum D90 (left panel, left 
half), αTAP2 antiserum 116/5 (left panel, right half) or the monoclonal αMHC class I antibody 
3B10.7 (right panel). Precipitates were analyzed in Western blots probed for TAP1, TAP2, tapasin 
or MHC class I heavy chains. TAP subunits are shown as pictograms. (D) Association of 1∆N or 
wild-type TAP with accessory chaperones of the PLC. Digitonin lysates of transfectants expressing 
wild-type TAP or the 1∆N single chain were subjected to immunoprecipitation using the αTAP1 
antiserum D90. Precipitates were analyzed in Western blots probed for TAP2, tapasin, MHC class 
I heavy chains, Calreticulin or ERp57.    
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To investigate whether the single TAP chain variants become recruited into the PLC, 
1∆N and 2∆N were immunoprecipitated from lysates of the cell lines T2(1∆N) or 
T2(2∆N) with either anti-TAP1 (D90) or anti-TAP2 (116/5) antisera (Fig. 12C). The 
co-isolated polypeptides were analyzed in Western blots using specific antibodies 
recognizing tapasin and MHC class I. Consistent with the data on the tandem 
transporter variant TD1∆N/2∆N (Fig. 11A) the single chain 2∆N was not found in 
association with any of the components of the PLC at all (Fig. 12C left panel and data 
not shown). Surprisingly however, the single expressed 1∆N fully retained the ability 
to interact with tapasin and MHC class I suggesting that the core TMD of the TAP1 
chain allows efficient complex formation (Fig. 12C left panel). To verify this, 
immunoprecipitations using anti-MHC class I antibodies were performed (Fig. 12C, 
right panel). In accordance with the results of the anti-TAP immunoprecipitations, 
1∆N, but not 2∆N co-precipitated with MHC class I molecules (Fig. 12C, right panel). 
Furthermore, to compare PLCs formed via the N-domains of wild-type TAP with 
PLCs formed via the core TMD of TAP1, lysates of the cell lines T2(TAPwt) and T2 
(1∆N) were subjected to immunoprecipitation using the TAP1-specific antiserum D90. 
Co-isolated polypeptides were subsequently separated by SDS-PAGE and analyzed 
by Western blot (Fig. 12D). Consistent with the finding that wild-type TAP does not 
associate with more MHC class I than the two variants 1-2∆N or 2-1∆N (Fig. 7B and 
Fig. 16) the amounts of MHC class I co-isolated with 1∆N and the wild-type 
transporter were roughly identical (Fig. 12D). Additionally, the amounts of calreticulin 
co-precipitating with 1∆N and TAPwt were also very similar. Thus it seems that the 
fully assembled transporter does not even associate with significantly higher levels of 
MHC class I and calreticulin as the 1∆N single chain. However, consistent with the 
finding that TAPwt interacts with tapasin via both TAP1 and TAP2 (Fig. 16) whereas 
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1∆N binds tapasin solely through its core TMD the levels of co-precipitated tapasin 
were significantly higher in the case of the wild-type transporter than of the single 
chain 1∆N (Fig. 12D). Consistent with the model that tapasin contributes to the 
recruitment of ERp57 into the PLC (Dick et al, 2002; Diedrich et al, 2001; Harris et al, 
2001) the levels of TAPwt-bound ERp57 versus 1∆N-bound ERp57 were also 
markedly higher (Fig. 12D).  
Furthermore, the subcellular distribution of the truncated TAP chains 1∆N and 2∆N 
was analyzed by indirect immunofluorescence. Fig. 13 shows that both subunits 
properly co-localized with KDEL-containing proteins in the ER. Thus, neither N-
domain is essential for ER-targeting of the respective TAP chain. Moreover, this 
Fig. 13 Subcellular localization of TAP single chain variants  
Intracellular localization of mutant TAP chains. T2 cells, expressing the indicated wild-type or 
mutant TAP subunit were fixed, permeabilized and co-stained with antibodies directed against the 
ER retention signal KDEL (MAC 256) and either TAP1 (D90) or TAP2 (116/5), followed by Alexa 
488- and Alexa 546-conjugated secondary antibodies. Cells were subsequently analyzed using a 
Zeiss Axioplan II fluorescence microscope.    
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experiment excludes that the different tapasin-interaction of 1∆N and 2∆N is caused 
by a distinctive intracellular localization of the truncated subunits.   
Taken together, it seems that depending on the assembly state of TAP1 different 
subregions of TMD1 are used for the interaction with tapasin whereas in TAP2 the 
tapasin-interaction is exclusively mediated by the N-domain. 
 
5.4 TAP variants 1-2∆N and 2-1∆N show different effects on the quality control 
of antigen presentation 
Tan and co-workers recently reported that MHC class I-loading with peptides 
conferring high complex stability requires the tapasin-mediated introduction of TAP 
into the PLC (Tan et al, 2002). To investigate whether and to what extend the 
tapasin-docking sites are required in the quality control of MHC class I processing the 
correlation between the thermostability of MHC class I molecules and the affinity for 
their peptide cargo was applied. The ability of MHC class I molecules to withstand 
thermal denaturation in cell extracts is directly related to the binding affinity of their 
peptide ligands (Williams et al, 2002). Consequently, at temperatures ≥37°C only the 
population of stably loaded MHC class I molecules resists irreversible disassembly 
(Baas et al, 1992; Williams et al, 2002). To explore the thermostability of assembled 
MHC class I in the established cell lines, lysates of the different transfectants were 
prepared and subsequently incubated for 1 hour at 4 °C or 37 °C (Fig. 14A and Fig. 
14B). The integrity of MHC class I complexes was tested by immunoprecipitations 
with the HLA-B5-specific β2m-dependent monoclonal antibody 4E (Trapani et al, 
1989); Tector et al, 1995). In transfectants expressing wild-type TAP or 2-1∆N the 
majority of HLA-B5 was found to be heat-stable (Fig. 14A lanes 2 and 5, for 
quantification see Fig. 14B) whereas in cells expressing 1-2∆N or no TAP most of the 
MHC class I-peptide complexes did not survive the incubation at 37°C (Fig. 14A 
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Fig. 14 In vitro thermostability of MHC class I in detergent extracts 
(A) Thermostability of MHC class I in cell extracts. Lysates of T2 transfectants were pre-treated or 
not with 10 µM HLA-B5 binding peptide EBV-3C/881-9 (QPRAPIRPI) and incubated for 1h at 4 °C 
or 37 °C. The thermostability of HLA-B5 was analyzed by immunoprecipitation of MHC class I from 
these extracts using either the conformation-independent monoclonal antibody 3B10.7 (top) or the 
β2-microglobulin-dependent monoclonal antibody 4E (bottom). Precipitates were analyzed in 
Western blots probed with the antibody 3B10.7. (B) The levels of precipitated MHC class I heavy 
chain were quantitated from the Western blot shown in Fig. 14A by densitometric scanning and 
peak integrals were plotted as bar graphs in arbitrary units. 
lanes 1 and 6, for quantification see Fig. 14B). Instability of HLA-B5 could be also 
seen for transfectants expressing tandem transporters TD1/2∆N or TD1∆N/2∆N (Fig. 
14A lanes 3 and 4, for quantification see Fig. 14B). In contrast, no temperature 
effects were observed in control experiments where immunoisolations were 
performed with the conformation-independent anti-MHC class I antibody 3B10.7 (Fig. 
14A, for quantification see Fig. 14B). To elucidate whether the observed heat-
sensitivity of the MHC class I molecules is due to suboptimal peptide-binding, lysates 
were pre-incubated with the high affinity HLA-B5 peptide ligand EBV-3C/881-9 
(QPRAPIRPI, in single letter amino acid code) (Hill et al, 1995) before incubation at 
37°C. As can be seen from Fig. 14A (for quantification see Fig. 14B), the pre-
treatment with peptides lead to a significant stabilization of HLA-B5 in cells 
expressing 1-2∆N, TD1/2∆N or TD1∆N/2∆N or no TAP at all. Thus, the presence of 
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the N-domain in TAP2, albeit not being essential for MHC class I processing, 
appears to be required for the formation of stable MHC class I complexes. To 
validate this idea, the thermostability of intracellular and cell surface HLA-B5 
complexes in intact cells was analyzed. For these studies the transfectants 
T2(TAPwt), T2 (1-2∆N) and T2 (2-1∆N) were used as these display comparable 
levels of TAP expression (Fig. 5B). Since assembled MHC class I molecules have a 
much higher heat-resistance under physiological conditions than in detergent 
extracts (Batalia et al, 2000), transfectants were heat-shocked for 10 min at 40, 50 
and 60°C or not heat-shocked at all. To determine thermostability of surface HLA-B5, 
cells were directly immunostained with the monoclonal antibody 4E whereas for the 
analysis of intracellular HLA-B5, transfectants were first permeabilized and then 
immunostained for flow cytometry. The experiments in Fig. 15A show that the cell 
lines expressing TAPwt or variant 2-1∆N were characterized by a high thermostability 
of intracellular HLA-B5 whereas in non-transfected T2 cells only 20% of intracellular 
HLA-B5 remained stable at 40°C and ≤10% at temperatures above 50°C. In line with 
the experiments shown in Fig. 14, the T2-transfectant expressing variant 1-2∆N 
showed a remarkable thermolability of intracellular HLA-B5 at temperatures >40°C 
(40 and 70% reduction of the intracellular immunostaining at 50 and 60°C, 
respectively). However, most surprisingly, all analyzed transfectants displayed a 
comparable high thermostability of surface HLA-B5. Accordingly, in the presence of 
the drug brefeldin A (BFA), which blocks the ER-Golgi transport, the time course of 
MHC class I-decay from the cell surface was determined to be almost identical (t1/2 = 
15h) among the cell lines T2(1-2∆N), T2(2-1∆N) and T2(TAPwt) (Fig. 15B), also 
indicating similar surface class I stability in these transfectants. Taken together, this 
suggests that in the cell line T2(1-2∆N) the population of HLA-B5 molecules on the 
cell surface is physically more stable than the intracellular fraction of HLA-B5.  
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Fig. 15 Stability of MHC class I molecules in intact cells  
(A) Thermostability of intracellular and cell surface MHC class I. Transfectants were collected in 
PBS / 0,1% NaN3 before incubation at 4, 40, 50 or 60 °C for 10 min. To examine the 
thermostability of surface HLA-B5, cells were directly immunostained with the monoclonal αMHC 
class I antibody 4E. To analyze the thermostability of intracellular HLA-B5, transfectants were 
fixated, permeabilized and stained with antibody 4E. After incubation with FITC-labeled secondary 
antibody HLA-B5 levels were determined by flow cytometry. (B) Survival of MHC class I molecules 
on the cell surface. Transfectants were treated with brefeldin A (BFA) that inhibits protein export 
from the ER. After culturing the cells for the time indicated, MHC class I surface molecules were 
stained with antibody 4E. Results of the flow cytometry are presented as percentage of the 
reduction in the mean fluorescence intensities (MFI) at 1, 2, 4, 12 and 15h compared with the MFI 
at 0h. (C) Maturation and thermostability of MHC class I. Transfectants were pulse-labeled for 30 
min and chased for the indicated times. Subsequently, cells were lysed in the presence or 
absence of 10 µM peptide EBV-3C/881-9 (QPRAPIRPI) and incubated for 1h at 37 °C. 
Immunoprecipitates recognized by the antibody 4E were digested with endoglycosidase H and 
separated by SDS-PAGE (left panel). Obtained signals of MHC class I heavy chains (ER and post-
ER) were quantitated and the bands with the highest intensity were set to 100% (right panel). 
To investigate whether stabilization of HLA-B5 complexes can occur during the 
intracellular transport to the cell surface, pulse-chase experiments were performed 
with the different transfectants (Fig. 15C). Cell lysates at different time points were 
heat-treated at 37°C for 1h in the presence or absence of the MHC class I-stabilizing 
peptide EBV-3C/881-9 (QPRAPIRPI, in single letter amino acid code) (Hill et al, 
1995) and subsequently incubated with endoglycosidase H. The fraction of 
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thermostable MHC class I molecules was assessed by immunoprecipitation with the 
conformation-sensitive monoclonal antibody 4E. Consistent with the experiments 
shown in Fig. 8A, Fig. 8B and Fig. 8C the ER-export rate of total HLA-B5 was found 
to be similar in T2(TAPwt), T2(1-2∆N) and T2(2-1∆N) as determined in the presence 
of stabilizing peptide (Fig. 15C, closed symbols). Furthermore, without the addition of 
external peptides MHC class I molecules of T2(TAPwt) or T2(2-1∆N) showed high 
thermostability when they had left the ER (Fig. 15C, open symbols). However, the 
situation was different in the cell line T2(1-2∆N) as here MHC class I molecules were 
thermolabile even after their export from the ER (Fig. 15C, open symbols). Moreover, 
comparison of the signals of the Endo H-resistant MHC class I isolated in the 
presence or absence of stabilizing peptides revealed that in T2(1-2∆N) the ER-
exported MHC class I molecules improved their thermostability during the process of 
post-ER maturation (Fig. 15C).  
The experiments described above suggest that PLCs formed by the TAP variant 1-
2∆N have lost their quality control function in the generation of stably loaded MHC 
class I. Furthermore, the presented data provides evidence that structural stability of 
MHC class I complexes can be rescued in the late compartments of the secretory 
route. 
 
5.5 The N-domain of TAP2 is essential for the structural integrity of the PLC 
To elucidate the molecular basis for the defective quality control of MHC class I 
processing in transfectants expressing 1-2∆N the composition of PLCs comprising 
the TAP variants TAPwt, 1-2∆N or 2-1∆N was analyzed. The proper assembly of the 
PLC may be of central significance as in addition to tapasin, also the accessory 
chaperones ERp57 and calreticulin are thought to play a critical role in the quality 
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Fig. 16 Composition of PLCs comprising TAP variants 2-1∆N and 1-2∆N 
Comparative analysis of PLC formation by wild-type TAP, 2-1∆N and 1-2∆N. Immunoblots of SDS-
PAGE-separated proteins from αTAP2 precipitates were probed for TAP1, TAP2, tapasin, MHC 
class I heavy chains, ERp57, calreticulin or calnexin. The relative intensities of signals quantified 
by densitometric scanning are shown as bar graphs. 
control of MHC class I loading (Wright et al, 2004). Recent models propose that the 
functional interplay of all three components is required for the optimization of the 
peptide cargo for MHC class I within the PLC (Gao et al, 2002; Dick et al, 2002). This 
is also reflected in the high cooperativity of interactions among the different PLC 
components (Harris et al, 2001; Hughes et al, 1998; Momburg et al, 2002; Sadasivan 
et al, 1996). Therefore, the complex formation of 1-2∆N and 2-1∆N with ERp57 and 
calreticulin was examined by immunoprecipitation, using the TAP2-specific antiserum 
116/5. Additionally, the association of the transporter variants with calnexin, which is 
thought to be a component of the so-called precursor-complex that precedes the 
formation of the PLC (Diedrich et al, 2001) was analyzed. The TAP immunoblots of 
SDS-PAGE-separated precipitates showed comparable amounts of wild-type and 
truncated TAP chains, demonstrating that immunoisolations from all three cell lines 
had been equally efficient (Fig. 16). In accordance with the experiments shown in 
Fig. 7, comparable co-isolation of MHC class I was also observed (Fig. 16). 
Furthermore, in support of the model that calreticulin becomes inserted into the PLC 
together with MHC class I (Diedrich et al, 2001) identical amounts of this chaperone 
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were found in the complexes of wild-type TAP and 2-1∆N (Fig. 16). It is worth to note 
that this is reminiscent of the similar levels of MHC class I and calreticulin co-
precipitating with TAPwt and the single chain 1∆N (Fig. 12D). However, the amount 
of tapasin, ERp57 and calnexin co-isolated with 2-1∆N equalled half the amount co-
isolated with the wild-type transporter indicating that in 2-1∆N solely the N-domain of 
TAP2 is involved in the formation of precursor and/or peptide-loading complexes 
(Fig. 16). As seen before (Fig. 7), the interaction of 1-2∆N with tapasin and MHC 
class I resembled the properties of complexes formed by variant 2-1∆N (Fig. 16). Yet, 
in striking contrast to 2-1∆N, the quantities of accessory chaperones co-precipitated 
with 1-2∆N were significantly diminished. The amounts of co-isolated ERp57, 
calnexin and calreticulin corresponded to 10, 15 and 40% of that found in the 
complex of TAPwt. This indicates that either the steady state levels of these 
chaperones in PLCs comprising 1-2∆N are drastically reduced or that the interactions 
among the polypeptides within these PLCs are substantially weaker so that the 
accessory components are lost during the immunoprecipitation procedure. In any 
case, despite efficient recruitment of tapasin and MHC class I to the N-domain of 
TAP1 in 1-2∆N, the formation of precursor- and/or peptide-loading- complexes 
seems to be markedly disturbed in the cooperative assembly of accessory 
chaperones. It is reasonable to assume that this is directly responsible for the 
defective quality control of MHC class I loading observed in cells expressing variant 
1-2∆N. 
 
5.6 Calnexin is part of the peptide loading complex in T2 cells expressing TAP 
The experiments depicted in Fig. 16 showed that the instability of intracellular MHC 
class I molecules in the cell line 1-2∆N correlated with diminished co-isolation of 
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calnexin with TAP. This was surprising, as calnexin had previously not been reported 
to be a component of the PLC in human cells, but instead to transiently associate via 
tapasin with TAP in a so-called precursor complex before MHC class I becomes 
inserted along with calreticulin (Diedrich et al, 2001). Nevertheless, this view on the 
assembly of the PLC contrasts with observations regarding the mature loading 
complex in murine cells that was shown to comprise significant levels of the 
membrane-anchored lectin chaperone (Suh et al, 1996). Thus, to address the 
question whether calnexin associates with the PLC in human T2 cells expressing 
TAPwt, 1-2∆N or 2-1∆N, respective cell extracts were subjected to consecutive 
immunoprecipitation to isolate mature loading complexes, which contain TAP and 
MHC class I at the same time. Therefore, in a first step TAP-associated polypeptides 
were precipitated from digitonin lysates of the cell lines T2(TAPwt), T2(1-2∆N) and 
T2(2-1∆N) using the TAP2-specific antiserum 116/5. Subsequently, bound protein 
complexes were eluted by competition with a peptide corresponding to the C-
terminus of TAP2 (EQDVYAHLVQQRLEA, in single letter amino acid code) 
(Momburg et al, 1992). An aliquot of this eluate was saved for Western blot analysis 
of TAP-associated proteins (Fig. 17A, lanes 1, 2 and 3) before complexes were re-
precipitated with the monoclonal anti-MHC class I antibody 3B10.7. Isolated PLCs 
were separated by SDS-PAGE and analyzed by Western blot using antisera directed 
against calnexin, TAP1 or MHC class I (Fig. 17A, lanes 4, 5 and 6). Fig. 17A (lane 4) 
shows that significant amounts of calnexin were found in complexes that 
simultaneously comprised TAPwt and MHC class I, indicating that the lectin 
chaperone is indeed a component of the mature PLC in T2 cells expressing the wild-
type transporter. However, the total amount of calnexin associated with TAP was 
determined to be somewhat larger than its amount in TAP-MHC class I complexes 
(Fig. 17A, compare lane 1 and 4). This difference may reflect the co-existence of 
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Fig. 17 Association of calnexin with the PLC 
A) Association of calnexin with the PLC. TAP-associated proteins were immuno-isolated from 
digitonin lysates of cells expressing TAPwt, 2-1∆N or 1-2∆N, using the TAP2-specific antiserum 
116/5. Bound complexes were eluted by competition with peptide, corresponding to the C-
terminus of TAP2 and re-precipitated with the anti-MHC class I-specific antibody 3B10.7. SDS-
PAGE-separated proteins were transferred onto nitrocellulose membrane and stained with 
antisera, directed against calnexin, TAP1 or MHC class I. B) ALLN enhances the physical 
interaction between calnexin and TAP. T2 transfectants were incubated in the absence or 
presence of the proteasome inhibitor ALLN and lysed either immediately or after removal of the 
inhibitor followed by overnight-incubation in ALLN-free medium. TAP2-associated proteins were 
isolated and analyzed by Western blot. C) The levels of TAP2-bound calnexin were quantitated 
from the Western blot shown in Fig. 17B by densitometric scanning and peak integrals, normalized 
for precipitated TAP1 were plotted as bar graphs. D) ALLN application does not induce calnexin 
recruitment into PLCs comprising 2-1∆N. PLCs were isolated by consecutive immunoprecipitation 
form digitonin-lysates of ALLN-treated cells as in Fig. 17A. Anti-TAP2-immunoprecipitates from the 
first round of IP (left panel) or mature PLCs isolated by consecutive IP (right panel) were 
separated by SDS-PAGE and analyzed by Western Blot.  
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precursor complexes (that lack MHC class I) and mature loading complexes (that 
contain MHC class I) in the cell. Alternatively, this result might also be explained by 
some loss of calnexin from the PLC during the consecutive immunoprecipitation. 
 
5. Results 70
Nevertheless, in either case a significant fraction of TAP-MHC class I-complexes 
appears to be concomitantly associated with calnexin. In line with the results shown 
in Fig. 16 calnexin also co-precipitated with both truncation variants of the 
transporter. As expected (see Fig. 16), variant 2-1∆N associated with moderately 
reduced levels, whereas variant 1-2∆N bound dramatically reduced levels of the 
lectin chaperone when compared to TAPwt (Fig. 17A, compare lane 1, 2 and 3). (It 
should be noted that in this experiment the levels of MHC class I co-isolated with 1-
2∆N (Fig. 17A, lane 3) as well as the levels of TAP1 co-precipitated with MHC class I 
from the respective eluate (Fig. 17A, lane 6) were somewhat lower than expected. 
This may be caused by a reduced precipitation efficiency, a partial disassembly of 
the less stable loading complexes formed by 1-2∆N or some proteolysis of 
precipitated proteins during the prolonged elution procedure at room temperature.) 
Nevertheless, the calnexin levels in mature PLCs formed by truncated TAPs were 
dramatically reduced (in the case of 2-1∆N) (Fig. 17A, lane 5) or not detectable at all 
(in the case of 1-2∆N) (Fig. 17A, lane 6). This indicates that the presence of the lectin 
chaperone and MHC class I in the loading complexes comprising 1-2∆N or 2-1∆N is 
mutually exclusive. Moreover, the distinctive interaction of calnexin with PLCs formed 
by truncated TAPs and TAPwt demonstrates that the observed association of the 
lectin chaperone with the wild-type loading complex is indeed specific. This 
underscores that calnexin is a regular component of the mature PLC in human cells. 
In addition, the findings described in this thesis show also that the wild-type 
transporter at steady state associates with MHC class I solely via one but not 
simultaneously via both N-domains (Fig. 7B, Fig. 12D, Fig. 16). Thus, in combination 
of these findings it is tempting to speculate that the opposing tapasin-docking site 
 
5. Results 71
(currently not interacting with class I) is concomitantly involved in the transient 
calnexin interaction (Fig. 23).  
Treatment of cells with the cell-permeable proteasome inhibitor ALLN has been 
reported to enhance and extent the association of TAP with MHC class I molecules 
(Hughes et al, 1996). From these studies it had been concluded that under conditions 
that interfere with the availability of suitable peptide ligands in the ER lumen, empty 
MHC class I molecules stably accumulate in the PLC. One surprising result 
described above is that although both, TAP1 and TAP2 comprise a tapasin/MHC 
class I-docking site in their N-domain (Fig. 7 and Fig. 16) only one appears to be 
used for MHC class I-interaction at steady state (Fig. 7B, Fig. 12D, Fig. 16), whereas 
the other is occupied with calnexin (Fig. 17A and Fig. 23). Consequently, the 
question arises whether this organization of the loading complex indeed reflects a 
physical inability of class I to associate with both N-domains of TAP at the same time 
or if the observed steady state composition of the PLC is solely a result of the high 
dissociation rate of MHC class I from TAP caused by the optimal availability of 
peptide ligands. In the case of the latter scenario, it would be expected that under 
conditions where the peptide delivery into the ER is blocked (e.g. in the presence of 
the proteasome inhibitor ALLN), empty MHC class I molecules would displace 
calnexin from TAP and stably associate with both subunits of the transporter. To 
address this point, the cell line T2(TAPwt) was grown in the presence or absence of 
250 µM ALLN for 4 hours before lysis in digitonin-containing buffer and precipitation 
of TAP-associated polypeptides using the TAP2-specific antiserum 116/5. 
Interestingly, Western blot analysis of co-isolated proteins did not show any 
increased levels of MHC class I bound by TAP in the presence of ALLN in three 
independent experiments, one of which is shown in Fig. 17B (compare lane 4 and 5), 
indicating that in non-treated cells all available docking-sites for MHC class I are 
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already saturated at steady state. Furthermore, the results shown in Fig. 17B 
underscore that even under conditions of extreme peptide starvation MHC class I 
molecules are not able to displace calnexin from TAP. This demonstrates that 
peptide supply does not affect the usage of tapasin-docking sites in the PLC by MHC 
class I. Consequently, the association of MHC class I molecules with both N-domains 
of TAP at the same time is a structural state that cannot be attained by the PLC. One 
possible explanation may be that the formation of a loading complex via one N-
domain sterically hinders the formation of a corresponding complex at the docking-
site in the opposing TAP subunit. Surprisingly, the calnexin signals recovered with 
TAP were significantly increased in the presence of the proteasome inhibitor (Fig. 
17B, compare lane 4 and 5, for quantification see Fig. 17C). This is not due to an 
increase in overall TAP levels in the lysate as the proteasome inhibitor did not affect 
TAP expression (Fig. 17B).  Thus, the results shown in Fig. 17B indicate that either 
additional calnexin molecules are recruited into the PLC upon proteasome inhibition 
or that the association of calnexin with the PLC is structurally stabilized in the 
absence of peptide supply. As the observed increase of co-isolated calnexin in the 
anti-TAP immunoprecipitation is not paralleled by a comparable decrease in co-
isolated MHC class I it can be excluded that additional calnexin molecules occupy 
binding sites in the PLC that had previously been associated with class I (Fig. 17B; 
see also Fig. 17D, left panel). Thus, the finding that more calnexin can be co-
precipitated with TAP in the presence of ALLN is more likely to reflect an enhanced 
physical interaction between TAP and the lectin chaperone than an increase in the 
total number of bound calnexin molecules per PLC. As a recent study suggests that 
peptide-occupation of TAP qualitatively affects its tapasin-mediated interaction with 
class I (Owen et al, 2001), a similar view may be applied for the tapasin-mediated 
interaction of calnexin with the transporter. It is plausible to assume that in the 
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presence of ALLN an intermediate of the PLC is trapped, which corresponds to the 
state where TAP is not associated with cytosolic peptide substrates. Possibly, this 
intermediate is characterized by a higher affinity for the lectin chaperone. One 
prediction that such a model would make, is that the enhanced physical interaction 
between TAP and calnexin observed under conditions of peptide starvation should 
become reversed upon the restoration of the peptide supply into the ER. To validate 
this, T2(TAPwt) cells were treated with 250 µM ALLN for 4 hours, followed by 
extensive washing for removal of the proteasome inhibitor and subsequent over-night 
incubation in ALLN-free medium. 24h later the cells were lysed and TAP-associated 
polypeptides were isolated with the TAP2-specific antiserum 116/5. As expected 
Western blot analysis of the co-isolated proteins showed that the signals for calnexin 
recovered with anti-TAP2 antiserum under these conditions returned to levels 
observed for non-treated cells (Fig. 17B and Fig. 17C). To confirm the results shown 
in Fig. 17B mature MHC class I-containing loading complexes were isolated by 
consecutive immunoprecipitation (as for Fig. 17A) from ALLN-treated T2(TAPwt) or 
T2(2-1∆N) cells. Consistent with the finding that in the presence of ALLN MHC class I 
does not displace calnexin from the wild-type PLC, TAPwt and 2-1∆N bound 
comparable levels of class I even when the proteasome inhibitor was applied (Fig. 
17D, left panel). Furthermore, in line with the idea that binding of calnexin and MHC 
class I to the truncated transporters is mutually exclusive mature loading complexes 
formed by 2-1∆N did not show any detectable association with the lectin chaperone 
(Fig. 17D, right panel). In contrast, calnexin was clearly present in PLCs formed by 
TAPwt (Fig. 17D, right panel). Finally, the results shown in Fig. 17D provide further 
evidence that PLCs comprising 2-1∆N contain only one of the two docking sites for 
the recruitment of tapasin and ERp57. Nevertheless, as expected from the results 
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depicted in Fig. 7B and Fig. 16 MHC class I associates comparably with mature 
PLCs formed by wild-type TAP or 2-1∆N.  
Taken together, the results shown in Fig. 17 support a model of the PLC wherein one 
N-domain of TAP is involved in tapasin-mediated interaction with MHC class I, 
whereas the opposing N-domain is simultaneously involved in the transient tapasin-
mediated interaction with calnexin (Fig. 23). 
 
5.7 Calnexin is not essential for recruitment of ERp57 into the loading complex 
or for the quality control of antigen presentation 
The results depicted in Fig. 16 suggest that the truncation variant 1-2∆N associates 
with significantly lower levels of ERp57, calreticulin and calnexin than the wild-type 
transporter. Since ERp57 is believed to become recruited to its substrate proteins via 
binding to one of the two lectin chaperones (Ellgaard et al, 2004) the question arose 
whether calnexin is responsible for the insertion of the oxidoreductase into the PLC. 
To address this question, TAP-associated proteins were co-isolated with the 
monoclonal TAP1-specific antibody 148.3 from digitonin lysates of the calnexin-
proficient human T cell leukaemia cell line CEM or its calnexin-deficient derivative 
CEM-NKR (Fig. 18A). Precipitates were analyzed by Western blot using antibodies 
targeted against TAP1, calreticulin, tapasin and ERp57 (Fig. 18B). Interestingly, 
PLCs derived from CEM-NKR cells displayed no reduction in ERp57 association, 
indicating that calnexin is not essential for recruitment of ERp57 into the PLC.  
The results depicted in Fig. 17A and Fig. 17D suggest that calnexin and MHC class I 
do not concomitantly associate with the same TAP subunit in the wild-type loading 
complex. This might argue against a direct influence of calnexin on the loading of 
MHC class I molecules. However, as roles for the other components of the PLC in 
the quality control of antigen presentation have been proposed (Dick et al, 2002; Gao 
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Fig. 18 Characterization of the peptide loading complex and MHC class I stability in cells 
lacking calnexin 
A) Expression of calnexin. Cell lysates were analyzed in a Western blot probed for calnexin. B)
Comparison of PLC formation. Immunoblots of SDS-PAGE-separated proteins from αTAP1 
precipitates were probed for TAP1, tapasin, ERp57 and calreticulin. C) Thermostability of 
intracellular MHC class I in CEM and CEM-NKR cells. Cells were collected in PBS / 0,1% NaN3
before incubation at 4, 40, 50 or 60 °C for 10 min. Subsequently, cells were fixated, permeabilized 
and stained with the monoclonal αMHC class I antibody w6/32. After incubation with FITC-labeled 
secondary antibody MHC class I levels were determined by flow cytometry.
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et al, 2002; Tan et al, 2002; Williams et al, 2002), it was analyzed whether or not 
calnexin is a part of the machinery that directs the generation of stable MHC class I 
molecules in the ER. Therefore, the thermostability of intracellular MHC class I 
molecules in calnexin-deficient CEM-NKR cells and their calnexin-proficient 
counterparts CEM was examined by flow cytometry (Fig. 18C). For these studies the 
monoclonal anti-MHC class I antibody w6/32 (Barnstable et al, 1978) was employed, 
which recognizes β2m-associated HLA-A, HLA-B and HLA-C molecules. Fig. 18C 
shows that the total MHC class I population in calnexin-positive CEM cells displayed 
a higher thermolability than HLA-B5 in T2(TAPwt) cells (Fig. 15A). Allele-specific 
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differences in MHC class I stability (Zernich et al, 2004) are likely to account for this. 
However, no further reduction of MHC class I thermostability could be observed in 
calnexin-deficient CEM-NKR cells, suggesting that calnexin has at least no significant 
influence on the stability of the MHC class I alleles expressed in CEM cells.  
 
5.8 High level MHC class I surface expression in the cell line T2(1-2∆N) 
depends on the proteolytical activity of proprotein convertases  
The data regarding the stability of MHC class I in the established cell lines (Fig. 14 
and Fig. 15) showed that the fraction of surface HLA-B5 in the transfectant T2(1-
2∆N) was significantly more thermoresistant than the intracellular population (Fig. 
15A). Since the stability of this class I allele improved over time in a post-ER 
compartment (Fig. 15C) the question arose, which cellular mechanism was 
responsible for the observed effect. To address this point, it was first determined 
whether the transfectants expressing 1-2∆N gained stability of surface HLA-B5 
complexes by an increased rate of endocytic recycling and re-loading of MHC class I 
with peptides generated by endosomal processing. Therefore, the cell lines 
T2(TAPwt), T2(1-2∆N) or T2(2-1∆N) were grown in the presence of primaquine (Fig. 
19, grey bars) or NH4Cl (Fig. 19, white bars) before HLA-B5 surface levels were 
analyzed by flow cytometry. Primaquine is a drug that causes intracellular 
accumulation of endocytosed proteins including MHC class I molecules through a 
block in endocytic recycling (Reid et al, 1990) whereas NH4Cl inhibits endosomal 
processing (Ohkuma et al, 1978). Interestingly, the different transfectants showed 
almost identical reductions in the surface presentation of HLA-B5 in the presence of 
the lysosomotropic reagents (up to 25% for primaquine, see Fig. 19). This indicates 
that the analyzed cell lines do not markedly differ in the endocytic recycling and 
processing of surface MHC class I. 
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Fig. 19 Endocytic recycling and endosomal processing of MHC class I 
Expression of surface HLA-B5 in the presence or absence of primaquine or NH4Cl was analyzed 
by flow cytometry. Results are plotted as percentage of reduction of the MFI compared with the 
MFI of the control experiments.  
  
Stryhn and co-workers had proposed that suboptimally loaded MHC class I 
molecules, which are exported from the ER, may exchange peptide ligands with low 
affinity in the acidic milieu of the late secretory compartments (Stryhn et al, 1996). 
Furthermore, proprotein convertases (PCs) (Seidah et al, 1998), some of which are 
known to cycle between the trans-Golgi network (TGN), plasma membrane and 
endosomes (Rockwell et al, 2004; Seidah et al, 1998), have been reported to be 
involved in the generation of peptide antigens for MHC class I (Gil-Torregrosa et al, 
2000; Zhang et al, 2001). Thus, one promising hypothesis was that the improvement 
of MHC class I stability in the cell line T2(1-2∆N), which occurred along the exocytic 
route reflected re-loading of unstable MHC class I molecules in the TGN with 
proprotein convertase-generated peptides (see working model in Fig. 24). The 
human genome encodes at least seven highly related members of the 
subtilisin/kexin-like prohormone convertase family of serine proteases (Seidah et al, 
1998). Two of these, namely PC1 and PC2 are exclusively expressed in endocrine 
and neuroendocrine cells (Bennett et al, 1992; Seidah et al, 1990; Seidah et al, 
1992), whereas PC4 has been reported to be expressed solely in testis (Nakayama 
et al, 1992). However, the remaining four members of the proprotein convertase 
family, namely furin (Roebroek et al, 1986), PC5 (Mercure et al, 1996), PC7 
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(Bruzzaniti et al, 1996) and PACE4 (Kiefer et al, 1991) are known to display a 
widespread tissue distribution (Bruzzaniti et al, 1996; Hatsuzawa et al, 1990; Kiefer 
et al, 1991; Lusson et al, 1993; Mercure et al, 1996; Seidah et al, 1996; Tsuji et al, 
1994). As T2 cells derive from a hybrid ancestor (T1) generated by the fusion of a B-
lymphoblastoid cell line (LCL 721.174) with a T- lymphoblastoid cell line (CEM) 
(Salter et al, 1985), it is interesting to note that several B-cell lines were also reported 
to express furin and PC7 (Zarkik et al, 1997) while some T-cell lines additionally 
harbour PC5 (Decroly et al, 1996; Decroly et al, 1997). To investigate whether T2 
cells express any of the proprotein convertases displaying broad tissue distribution 
RT-PCR was performed using primers specific for furin, PC5, PC7 or PACE4 (Fig. 
20A). In this experiment the human hepatoma cell line HepG2 served as a positive 
control as previous studies had shown that this cell line expresses several PC 
members (Imamaki et al, 1999). mRNA prepared from both cell lines was kindly 
provided by C. Bekpen. As depicted in Fig. 20A transcripts of all four proprotein 
convertases could be readily detected in HepG2 cells, whereas the T2 cell line 
expressed solely furin and PC7. To additionally confirm at the protein level the 
presence of these two proprotein convertases in T2 cells respective lysates were 
separated by SDS-PAGE and analyzed by Western Blot using PC-specific antisera. 
As shown in Fig. 20B, bands corresponding to furin and PC7 could be detected in T2 
cell lysates at the expected size of approx. 92 kDa. To further analyze the subcellular 
distribution of furin and PC7 in T2 cell lines immunofluorescence studies were 
undertaken. The fluorescence signal measured for PC7 was found to be most 
intense in a juxta-nuclear region that seemed to consist of several membranous 
subcompartments (Fig. 20C-d and Fig. 20C-e). Additionally, some cells displayed 
strong anti-PC7 immunoreactivity associated with vesicular structures immediately 
beneath the plasma membrane (Fig. 20C-f). This is consistent with earlier 
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descriptions of PC7 as a proprotein convertase distributed within the TGN (Van de 
Loo et al, 1997) or post-TGN vesicles (Wouters et al, 1998). Furin was also found to 
Fig. 20 Expression of proprotein convertases in T2 cells 
(A) Detection of proprotein convertase transcripts by RT-PCR. mRNA derived from T2 or HepG2 
cells (kindly provided by C. Bekpen) served as a template for RT-PCR using proprotein 
convertase-specific primers. (B) Expression of furin and PC7 in T2 cells. Lysates of T2 cells were 
analyzed by Western blot using the furin-specific antiserum anti-Furin or the PC7-specific 
antiserum KP-1. (C) Subcellular localization of proprotein convertases in T2 cells. Cells were 
fixated, permeabilized and stained with proprotein convertase specific antisera followed by Alexa 
488-conjugated secondary antibody. Subsequently cells were analyzed using a Zeiss Axioplan II 
fluorescence microscope. (D) Specificity of furin and PC7 stainings. T2 cells were fixated, 
permeabilized and stained with proprotein convertase specific antisera. After incubation with Alexa 
488-labeled secondary antibody intracellular proprotein convertase levels were determined by flow 
cytometry (filled histograms). Unspecific background staining was analyzed by incubation with 
secondary antibody alone (non-filled histograms). 
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be partially distributed in Golgi-like structures (Fig. 20C-c). However, anti-furin 
immunoreactivity was clearly most prominent in small dots that appeared to be 
spread throughout the cell (Fig. 20C-a and Fig. 20C-b). This pattern strongly 
resembles the characteristic staining pattern of the endosomal system, suggesting 
that furin may be predominantly localized to endosomes in T2 cells. To confirm the 
specificity of the immunofluorescent stainings displayed in Fig. 20C flow cytometry 
analysis of proprotein convertase expression using the same combination of primary 
and secondary antibodies was performed (Fig. 20D). To investigate whether the high 
level of surface MHC class I expression in the cell line T2(1-2∆N) depends on the 
activity of proprotein convertases, surface MHC class I-recovery experiments in the 
presence of increasing concentrations of the PC-specific, cell permeable inhibitor 
hexa-D-arginine (HDA) (Fig. 21) were performed (Cameron et al, 2000; Sarac et al, 
2002). In T2 cells expressing wild-type TAP and 2-1∆N, the recovery of surface MHC 
class I was not or only slightly affected (Fig. 21). This suggests that in these two cell 
lines the proprotein convertase-dependent pathways play only a minor role in the 
generation of MHC class I ligands. However, transfectants expressing variant 1-2∆N 
showed in the presence of HDA a significant and concentration-dependent reduction 
(up to 45% at 100 µM HDA) of surface MHC class I suggesting that a substantial 
amount of HLA-B5 antigens originates from proteolytic products generated by furin or 
related PCs (Fig. 21).  
Thus, it seems that in a situation where the quality control in the loading complex fails 
a post-ER mechanism that depends on proprotein convertase-activity can rescue 
stable surface expression of MHC class I molecules (Fig. 24).  
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Fig. 21 Proprotein convertase-dependence of MHC class I surface expression 
Proprotein convertase-dependence of MHC class I surface expression. Cells were acid-washed to 
remove assembled surface MHC class I and incubated for 14h in the presence of increasing 
concentrations of the proprotein convertase inhibitor hexa-D-arginine. Subsequently, cells were 
stained with monoclonal antibody 4E followed by FITC-labeled secondary antibody and surface 
expression of HLA-B5 was determined by flow cytometry. Surface MHC class I staining in the 
presence of hexa-D-arginine is plotted as percentage of reduction of the MFI compared with the 
MFI of the control experiments. 
5.9 Proprotein convertase expression is differentially regulated by interferons 
at the transcriptional level 
The expression of diverse immune-relevant genes is regulated by interferons, among 
them many that play a role in the MHC class I antigen presentation pathway (Boehm 
et al, 1997). As interferons become secreted in the context of an acute infection 
(Boehm et al, 1997) the upregulation of a gene in response to these cytokines has in 
the past been regarded as indicative of an immune-related function. However, 
several abundant proteins that serve for housekeeping functions in the cell, but 
additionally play an important role in antigen presentation (e.g. the constitutive 
proteasome, calnexin or calreticulin) have not been reported to be induced by 
interferons. It is noted that the regulation of proprotein convertase expression in 
virally infected cells may be of particular interest as this class of furin-related 
proteases besides a possible role in antigen presentation (Fig. 21) is required for the 
proteolytic maturation of numberless viral proteins, including those of human 
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immunodeficiency virus (HIV) (Vollenweider et al., 1996), hepatitis B virus (HBV) 
(Messageot et al, 2003), severe acute respiratory syndrome coronavirus (SARS) 
(Bergeron et al, 2005), human respiratory syncytial virus (HRSV) (Gonzalez-Reyes et 
al, 2001), influenza A Hong Kong virus (HKV) (Basak et al, 2001), measles virus (Bolt 
et al, 1998), human cytomegalovirus (HCMV) (Vey et al, 1995) and ebola virus 
(Basak et al, 2001). Thus, in view of the finding that under certain conditions 
proprotein convertases contribute peptides to the MHC class I antigen presentation 
pathway (Fig. 21) the up- or downregulation of proprotein convertases in the context 
of a viral infection may turn out to be a two-edged weapon. To determine whether 
furin or PC7 are regulated at the transcriptional level by interferon-γ the human cell 
lines T2 (a lymphoblastoid cell line), THP-1 (a monocyte-derived cell line) or HeLa (a 
cervical carcinoma cell line) were stimulated with 200 U/ml interferon-γ for 24h before  
mRNA was prepared. This mRNA, which was kindly provided by C. Bekpen, served 
as a template in an RT-PCR in combination with furin- or PC7-specific primers. To 
control for the equal amount and quality of the mRNA derived from uninduced or 
induced cells, RT-PCR was performed with primers specific for the interferon-
unresponsive (Baldeon et al, 1998) housekeeping gene GAPDH (Hanauer et al, 
1984). Additionally, to validate that the induction with the indicated cytokine was 
successful, RT-PCR was carried out using primers specific for the genes hGBP1 
(Cheng et al, 1991) or MxA (Aebi et al, 1989), both of which encode immune-relevant 
GTPases (MacMicking et al, 2004) that have been reported to be highly upregulated 
upon interferon induction (Aebi et al, 1989; Andrews et al, 2002; Cheng et al, 1986). 
As shown in Fig. 22 the expression of PC7 was not or only moderately affected at the 
transcriptional level in all cell lines tested. However, furin transcripts were despite 
their apparent presence in uninduced cells only barely detectable (in T2 cells) or not 
detectable at all (in THP-1 and HeLa cells) in cells stimulated with interferon-γ (Fig. 
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Fig. 22 Interferon-regulation of proprotein convertase expression 
The human cell lines T2 (lymphoblastoid), THP-1 (monocyte-derived) or HeLa (cervical carcinoma) 
were stimulated for 24h with interferon-γ or interferon-β at a concentration of 200 U/ml or 2000 
U/ml, respectively. The mRNA that was subsequently prepared from the indicated cell lines was 
kindly provided by C. Bekpen for this experiment. RT-PCR was performed using this mRNA as a 
template in combination with proprotein convertase-specific primers. Equal amount and quality of 
mRNA isolated from induced and uninduced cells was controlled by RT-PCR using primers 
specific for GAPDH, an interferon-unresponsive housekeeping gene. The induction by interferons 
was controlled by RT-PCR using primers specific for the interferon-regulated genes hGBP1 or 
MxA. 
22). This clearly indicates that furin is strongly (and in some cell lines completely) 
downregulated at the transcriptional level in response to this cytokine. Hence, it is 
tempting to speculate that during most viral infections PC7 is the proprotein 
convertase that eventually rescues unstable MHC class I molecules in the trans-
Golgi-network whereas the expression of furin is repressed to impede viral 
replication. Interestingly, PACE-4 was also found to be strongly downregulated in 
HeLa cells in response to interferon-γ (Fig. 22). Thus, one may speculate that in the 
case of an infection the synthesis of a whole battery of enzymes, all characterized by 
overlapping cleavage-specificities and all able to promote the cleavage-activation of 
viral proteins (with varying efficiency) is switched off. Most interestingly, the treatment 
with interferon-β lead also to a dramatic decrease in the levels of furin transcripts in 
T2 cells suggesting that type Ι (α/β) and type ΙΙ (γ) interferons regulate the synthesis 
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of proprotein convertases in a coordinate and (possibly) synergistic manner as 
described in the case of many other genes (Boehm et al, 1997).  
Taken together, in diverse cell lines the expression of proprotein convertases at the 
transcriptional level appears to be distinctively modulated in response to interferons. 
Additionally, the results shown in Fig. 22 suggest that even under conditions of 
interferon-mediated downregulation of certain proprotein convertases, persistent 
expression of PC7 may allow for the continuing generation of MHC class I antigens in 
the trans-Golgi network. 
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6. Discussion 
6.1 At steady-state TAP does not simultaneously associate with MHC class I via 
both N-domains   
To investigate the function of the N-terminal tapasin-binding sites in TAP1 and TAP2 
for the proper processing of MHC class I molecules, TAP variants lacking the N-
domain in TAP1 (2-1∆N) or TAP2 (1-2∆N) were stably expressed in the human TAP-
negative cell line T2 (Fig. 5B). Both mutant transporters clearly bound peptides (Fig. 
6A) and displayed normal substrate translocation activity when compared to the wild-
type transporter (Fig. 6B). Consequently, MHC class I molecules were efficiently 
supplied with ligands in T2 transfectants expressing TAPwt, 1-2∆N or 2-1∆N. This 
was reflected in almost identical dissociation kinetics of MHC class I from the PLC 
(Fig. 7B), comparable ER-export rates of HLA-B5 (Fig. 8A and Fig. 15C, closed 
symbols), similar time-courses of HLA-B5 surface recovery (Fig. 8B) and equal 
steady state surface expression of both, HLA-B5 (Fig. 8C) and HLA-A2 (data not 
shown) in the established cell lines.  
Consistent with the results of others (Koch et al, 2004) a transporter variant lacking 
both N-regions (TD1∆N/2∆N) was shown to be completely excluded from the PLC 
(Fig. 11A), whereas a similar construct retaining the N-domain in TAP1 readily bound 
tapasin (Fig. 11A). This indicates that the N-terminus of TAP1 indeed acts as a 
docking site for the loading complex. Conversely, the capability of the heterodimeric 
variant 2-1∆N to form a PLC (Fig. 7A, Fig. 16 and Fig. 17D) implies that also the N-
domain in TAP2 acts as a tapasin binding module. In accordance with the above 
mentioned findings pulse-chase experiments showed that both N-domains are able 
to form functional loading complexes, from which MHC class I molecules dissociate 
following the acquisition of peptide cargo (Fig. 7B). Consequently, it is attractive to 
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Fig. 23 Current working-model for the peptide loading complex  
The results presented in this thesis argue for an asymmetric peptide loading complex, in which 
one N-domain of the central TAP molecule is involved in the tapasin-mediated MHC class I-
interaction, whereas the other associates with calnexin (CNX). A consequence of the postulated 
model is that both N-domains are simultaneously associated with tapasin and ERp57 at steady 
state. In contrast, the calreticulin (CRT)/MHC class I-subcomplex as well as calnexin are at any 
given time solely bound by one of the two TAP subunits.  
speculate that the two TAP subunits in the wild-type transporter normally alternate 
with each other in the tapasin-dependent recruitment of newly synthesized MHC 
class I molecules. As expected from the finding that both N-domains can act as 
docking sites for components of the PLC, the wild-type transporter appeared to 
associate with significantly higher levels of tapasin (and ERp57) than the two 
truncated transporters 1-2∆N and 2-1∆N (Fig. 16 and Fig. 17D). Hence, it is tempting 
to speculate that in the case of TAPwt both N-domains simultaneously interact with 
these chaperones (Fig. 23). Surprisingly, the situation was found to be completely 
different for MHC class I and calreticulin. Western blot analysis showed that both 
polypeptides were co-isolated in almost identical amounts with TAPwt, 2-1∆N and 
even the TAP single chain 1∆N (Fig. 12D, Fig. 16 and Fig. 17D). In addition also 1-
2∆N associated comparably with MHC class I molecules (Fig. 16). In accordance 
with these results, pulse-chase experiments displayed very similar kinetics for the 
release of MHC class I from wild-type TAP and the two truncated transporter variants 
(Fig. 7B). This finding and the observation that similar amounts of radiolabeled MHC 
class I co-precipitated with the three TAP variants at any time point of the pulse-
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chase experiment (Fig. 7B) indicates that during the chase period comparable 
amounts of newly synthesized radiolabeled MHC class I passed through the three 
different loading complexes. Thus, although wild-type TAP has the capability to 
recruit MHC class I via both subunits, it seems that in the functional PLC at any given 
time only one of two N-domains is actively involved in the tapasin-mediated 
recruitment, loading and release of newly synthesized MHC class I (Fig. 23). 
Interestingly, this holds true even under conditions of extreme peptide starvation in 
the presence of the proteasome inhibitor ALLN (Fig. 17D, left panel). It should be 
noted that these findings clearly contrast with the initial view on the PLC that 
speculated simultaneous binding of class I to both TAP subunits would favour the 
association of multiple MHC class I alleles with the transporter, thereby increasing 
the probability that a translocated peptide gains immediate access to an appropriate 
allele (Ortmann et al, 1997). This model founded on an early study regarding 
immunoisolated loading complexes, which suggested that one TAP heterodimer 
binds four tapasin and four MHC class I molecules at steady state (Ortmann et al, 
1997). However, as a recent report demonstrated that tapasin does not form dimers, 
trimers or tetramers (Bangia et al, 2005) the predicted stoichiometry would demand 
that four individual tapasin/MHC class I-complexes simultaneously interact with the 
transporter. Furthermore, taking into account the finding that at steady state solely 
one TAP subunit associates with MHC class I (Fig. 7B, Fig. 16 and Fig. 17D), a 
model would follow that claims that each of the two N-domains (comprising solely 3 
or 4 transmembrane helices, respectively) shares the capability to interact with four 
independent tapasin-MHC class I-complexes at the same time. Although the data 
presented in this thesis does not formally exclude such a PLC, it is not considered 
likely either. In better accordance with the results described here, another group 
investigated the composition of the human TAP-complex by velocity sedimentation 
 
6. Discussion 88
analysis and provided evidence for a TAP-associated loading complex with a lower 
number of tapasin and MHC class I molecules (Li et al, 1997). Nevertheless, the 
question remains why the transporter does not simultaneously use its N-domains for 
recruitment of MHC class I as both TAP subunits appear to be occupied with tapasin 
at steady state (Fig. 16 and Fig. 17D). One possible explanation may be that several 
viruses considerably interfere with the proper function of the transporter, which must 
be regarded as a bottleneck of the MHC class I antigen presentation pathway (Hewitt 
et al, 2003; Lybarger et al, 2005). Thus, under conditions of a viral infection one 
could speculate that it would be beneficial for the cell to increase the number of 
transporter molecules in order to titrate away viral effectors or at least to temporally 
defer a complete viral block of peptide delivery into the ER. This would be consistent 
with the induction of TAP by the inflammatory cytokine interferon-γ, which is secreted 
by T cells or NK cells in response to an acute infection (Boehm et al, 1997). 
Following this argument, it may be a more promising strategy for the cellular immune 
system to provide a huge number of TAP molecules each associated with one (or a 
small number of) MHC class I alleles than to assemble PLCs that comprise a high 
number of MHC class I alleles bound by a single TAP molecule that in the case of its 
inhibition would render all bound MHC class I molecules peptide-starved and thus 
useless for the immune response.  
 
6.2 Calnexin is a component of the mature human peptide loading complex 
Since several years it is known that the lectin chaperone calnexin associates with the 
loading complex in murine cells (Suh et al, 1996). However, a corresponding 
interaction in the human system has despite some efforts not been detected yet 
(Diedrich et al, 2001). Instead, as a final step of the PLC formation in human cells 
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calnexin was reported to become released from the so-called precursor complex 
rapidly upon (or concomitantly with) the insertion of MHC class I and calreticulin (Fig. 
4) (Diedrich et al, 2001). Consequently, the question arises whether the reproducible 
detection of calnexin in the mature PLCs of the transfectant T2(TAPwt) (Fig. 17A and 
Fig. 17D) reflects indeed a naturally occurring interaction in human cells or is solely 
due to the heterologous expression of rodent TAP. The latter possibility is unlikely as 
several lines of evidence point towards a role for tapasin, but not for TAP in the 
recruitment of calnexin into the PLC / precursor complex. First, tapasin was shown to 
retain the stable association with calnexin and ERp57 after cell lysis in Triton X-100, 
a detergent which is known to release TAP from the other components of the PLC 
(Diedrich et al, 2001). This indicates that TAP is not required to maintain the 
association of calnexin with tapasin and the oxidoreductase. Second, tapasin is 
capable of forming complexes with calnexin in TAP-negative T2 cells (data not 
shown), demonstrating that the peptide transporter is not essential to allow for an 
interaction between the two chaperones. Hence, these results suggest that tapasin, 
but not TAP directly recruits calnexin into the PLC. At present, one can only 
speculate why Diedrich and colleges did not detect calnexin in the human loading 
complex (Diedrich et al, 2001). Hitherto, it cannot be excluded that interactions 
among individual PLC components vary somewhat depending on the MHC class I 
alleles expressed in the cell as suggested by recent results of one group (Paquet et 
al, 2002). Thus, different class I alleles may reside in loading complexes with 
different compositions. However, it is more likely that calnexin-binding to the PLC 
was overlooked as its interaction with the PLC is presumably labile and thus easily 
broken. Surprisingly, the consecutive immunoprecipitation studies depicted in Fig. 
17A and Fig. 17D showed that the simultaneous association of TAP with calnexin 
and MHC class I is solely observed in the case of TAPwt, but not in the case of the 
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truncation variants 1-2∆N and 2-1∆N. As the two latter have not generally lost the 
ability to interact with calnexin (Fig. 16 and Fig. 17A) it must be inferred that both 
interactions are mutually exclusive in the truncated TAPs. Thus, calnexin-bound 
TAP-complexes formed by 1-2∆N and 2-1∆N are with regard to their molecular 
composition reminiscent of the precursor complexes postulated by Diedrich and 
colleges (Diedrich et al, 2001). Consequently, the results presented in Fig. 17A and 
17D do not rule out the existence of precursor complexes in human cells. Rather, it is 
possible that all docking-sites in the PLC that are occupied by MHC class I, were 
previously associated with calnexin. Hence, a model can be predicted, in which the 
docking-sites of the TAP-associated loading complex sequentially switch between 
two states: an MHC class I-associated loading state followed by a calnexin-
associated regeneration or maintenance state (see later). Importantly, the calnexin-
binding properties of the TAP truncation variants imply that the interaction of the 
lectin chaperone with the wild-type transporter occurs via that N-domain, which is 
currently not involved in the binding of MHC class I (see model of the PLC in Fig. 23). 
Interestingly, in the murine system the binding of peptide was shown to release MHC 
class I molecules from TAP but not from calnexin. From this result it was speculated 
that calnexin would ultimately determine whether a loaded MHC class I molecule 
becomes exported from the ER or not (Suh et al, 1996). Such a role for calnexin in 
the retention of murine class I-peptide complexes is consistent with a decelerated 
rate of egress reported for the assembled mouse-derived MHC class I allele H2-Kb 
from the ER when expressed in insect cells in combination with calnexin (Vassilakos 
et al, 1996). Nevertheless, the finding that in murine cells intact MHC class I-calnexin 
complexes become displaced from TAP upon peptide binding, suggests that here 
calnexin binds to the same TAP subunit as class I, making it plausible to speculate 
that the calnexin interaction described for the murine PLC (Suh et al, 1996) is 
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different from that described for the human PLC in this thesis. In line with this, no role 
for calnexin in the retention of assembled MHC class I molecules in human cells was 
found yet (Prasad et al, 1998; Scott et al, 1995). However, up to now it cannot be 
excluded that a concerted release of calnexin and peptide-loaded MHC class I from 
the two opposing N-domains in the human PLC is followed by an association of both 
components. Hitherto, it can only be speculated what the function of calnexin in the 
mature PLC may be. The immunoprecipitation study shown in Fig. 18B rules out that 
calnexin is essential for the recruitment of ERp57 into the loading complex. Thus, as 
calreticulin was also shown to be dispensable for the proper insertion of the 
oxidoreductase into the PLC (Gao et al, 2002) it is likely that either both lectin 
chaperones contribute to the incorporation of ERp57 in a redundant manner or that 
ERp57 is directly recruited by tapasin, to which it forms a disulfide bridge (Dick et al, 
2002). Furthermore, calnexin was shown to be clearly not essential for peptide-
loading, ER-export or surface expression of MHC class I as determined in the 
calnexin-deficient cell line CEM-NKR (Howell et al, 1985; Prasad et al, 1998; Scott et 
al, 1995; data not shown). Typically calnexin is known to play an important role in the 
folding pathway of glycosylated proteins in the ER (Fig. 3) (High et al, 2000). In 
addition, it can act as a molecular chaperone also on several non-glycosylated 
substrates (Ihara et al, 1999). Therefore, one promising hypothesis may be that the 
function of calnexin in the PLC is to maintain (and perhaps protect) the free MHC 
class I-docking site in a state that is competent for class I interaction. This would be 
in line with the finding that a treatment with ALLN enhances the physical interaction 
of calnexin with the PLC. (As this drug blocks the generation of peptides by cellular 
proteases its application may mimic the state of a viral infection, which is often 
characterized by reduced delivery of peptides into the ER through inhibition of TAP or 
the proteasome.) Presumably, such a function for calnexin would be dispensable and 
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hence difficult to observe in a non-infected healthy cell. However, it could become 
important in the context of a pathogenic challenge as several viruses interfere with 
the formation or the function of the PLC (Hewitt et al, 2003; Lybarger et al, 2005). 
One example for such a viral subversion strategy targeting the loading complex is the 
adenovirus protein E19 that binds to both, MHC class I and TAP in order to inhibit the 
interaction of both proteins (Bennett et al, 1999). Another example is the γ-
herpesvirus 68 (HV68) protein mK3 that associates with the TAP-tapasin-complex 
where it presumably awaits the entry of newly synthesized class I chains, on which it 
acts as a ubiquitin ligase (E3) to target them for degradation (Lybarger et al, 2005). In 
addition, recent studies implicated the mK3 polypeptide also with the degradation of 
TAP and tapasin in the cell (Boname et al, 2004). Calnexin may counteract the 
association of viral effectors as E19 and mK3 with the PLC and thereby reduce the 
efficiency of viral interference with the MHC class I antigen presentation pathway. 
Such a role for the lectin chaperone in maintaining (and possibly protecting) the 
loading complex appears to be plausible as under conditions of a viral attack the 
structural integrity and stability of the PLC is likely to be of even greater functional 
importance as under basal conditions. This is underscored by the high cooperativity 
among the interactions of the PLC components (Harris et al, 2001; Hughes et al, 
1998; Momburg et al, 2002; Sadasivan et al, 1996) to which calnexin would be also 
likely to contribute. Such a putative role of calnexin in protecting the class I docking 
sites or conferring additional structural stability on the PLC may also provide an 
explanation why TAP comprises tapasin-docking sites in both subunits, although the 
presence of solely one N-domain (in the 2-1∆N variant) appears to be completely 
sufficient for optimal peptide loading in all assays that were performed so far. 
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6.3 The N-region of TAP2 is essential for the structural and functional integrity 
of the peptide loading complex 
One of the crucial findings presented in this thesis is that T2-transfectants expressing 
variant 1-2∆N are characterized by a significant thermolability of intracellular MHC 
class I molecules when compared to the corresponding cell lines expressing 2-1∆N 
or wild-type TAP (Fig. 14 and Fig. 15). However, the observation that the two 
truncated transporters show comparable binding of tapasin and MHC class I (Fig. 16) 
indicates that the low class I-stability in the cell line T2(1-2∆N) is not due to a 
diminished interaction between 1-2∆N and  tapasin. Instead, in view of the well-
known correlation between the thermostability of MHC class I molecules and the 
affinity of their peptide cargo (Williams et al, 2002), it is reasonable to assume that in 
the presence of variant 1-2∆N suboptimal ligands are loaded onto class I, which fail 
to confer high stability on the resulting complex. This is consistent with previous 
studies that reported a significantly reduced stability of MHC class I molecules in 
human cell lines expressing tapasin variants, which lack TAP-association (Tan et al, 
2002; Williams et al, 2002). As these mutant tapasin molecules fail to recruit the 
transporter into the PLC, it was concluded that the incorporation of TAP into the 
loading complex is essential for an optimal quality control of peptide loading. 
However, by which mechanism TAP improves the stability of class I remained 
elusive. One promising scenario was that the “bridging function” of tapasin, which 
allows for a close structural proximity of TAP and MHC class I molecules within the 
PLC would increase the local peptide concentration. As a direct consequence, the 
diversity of available ligands for class I was postulated to become expanded, which in 
turn could lead to the acquisition of more optimal peptide cargo. However, as 1-2∆N 
displays normal interaction with MHC class I (Fig. 7B and Fig. 16) the results 
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described in this thesis demonstrate for the first time that the “bridging function” of 
tapasin is clearly not sufficient for the formation of stable MHC class I-peptide 
complexes. Instead, the experiments depicted in Fig. 16 show that the thermolability 
of MHC class I in the cell line T2(1-2∆N) (Fig. 14 and Fig. 15) correlates with a 
drastically reduced amount of accessory chaperones in the 1-2∆N-associated loading 
complex (Fig. 16). Nothing comparable is observed in the cell line T2(2-1∆N) (Fig. 
16). Quantitative evaluation of the corresponding immunoblots revealed that the 
amounts of tapasin and ERp57 co-isolated with 2-1∆N correspond to approx. 50% of 
those co-isolated with wild-type TAP. In contrast, the levels of calreticulin and MHC 
class I associated with 2-1∆N and TAPwt are roughly identical. This indicates that the 
transporter variant 2-1∆N forms a normal class I-loading site via TAP2, but lacks the 
tapasin/ERp57-interaction in TAP1. However, in the case of variant 1-2∆N, the 
signals for the co-isolated chaperones ERp57, calreticulin and calnexin were only 
barely detectable. Thus, despite the normal association of the TAP1 subunit with 
tapasin and MHC class I in the TAP variant 1-2∆N, this truncated transporter seems 
to be highly defective in the stable recruitment of chaperones. Nevertheless, neither 
the presence of ERp57 nor that of calreticulin in the PLC was reported to be essential 
for the process of peptide-loading onto MHC class I (Gao et al, 2002; Howarth et al, 
2004). Consistent with this, the kinetics for the release of MHC class I from the PLC 
were found to be identical among the cell lines T2(TAPwt), T2(1-2∆N) and T2(2-
1∆N). However, several recent studies point towards a critical role for ERp57 and 
calreticulin in the quality control of antigen presentation (Dick et al, 2002; Gao et al, 
2002). In this context it was speculated that the optimization of peptide cargo for 
MHC class I within the PLC is a multifactorial process where tapasin in cooperation 
with the accessory chaperones improves the efficient loading with those ligands that 
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confer high conformational stability. A recent working model postulates that tapasin 
optimizes peptides for MHC class I by deforming the peptide-binding pocket in a way 
that some stabilizing contacts to the peptide cannot be formed (Wright et al, 2004). 
Under these conditions, which broadly disfavour peptide-binding solely optimal 
ligands (those that comprise optimal anchor residues) would be expected to resist 
their dissociation from class I. However, the exact function of ERp57 and calreticulin 
in the loading complex is currently not known. One may speculate that both 
contribute to a further deformation of the peptide binding pocket in the class I 
molecule and thereby assist the tapasin-mediated peptide editing function. 
Additionally, it is also possible that ERp57, which possesses cysteine protease 
activity (Urade et al, 1992), acts as a peptide trimming enzyme within the PLC, 
thereby directly shaping the peptide repertoire loaded onto MHC class I molecules. 
Furthermore, since calreticulin was shown to bind peptides translocated by TAP 
(Spee et al, 1997) this lectin chaperone could protect optimal peptide ligands and 
help to efficiently deliver them onto peptide-receptive class I. Moreover, the results 
presented in this thesis show for the first time that in addition to ERp57 and 
calreticulin, also calnexin is a regular component of the mature human PLC (Fig. 17A 
and Fig. 17D). Although the data regarding the MHC class I stability in CEM cells 
(Fig. 18C) argues against a general role for calnexin in the quality control of peptide 
loading it cannot be excluded at present that this lectin chaperone may contribute to 
the stability of peptide-MHC class I complexes in the case of some MHC class I 
alleles. Thus, in accordance with the view that the accessory chaperones in the PLC 
significantly contribute to the generation of highly stable MHC class I-peptide 
complexes (Dick et al, 2002; Gao et al, 2002), the results shown in Fig. 14 and Fig. 
15 suggest that the PLCs formed by 1-2∆N have lost their quality control function in 
MHC class I loading by a failure in the chaperone-assisted peptide editing. 
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Interestingly, the experiments on the TAP variants 2-1∆N and 1-2∆N also indicate for 
the first time that the N-terminal tapasin-docking sites of TAP1 and TAP2 have 
different requirements for the stable binding of ERp57, calreticulin and calnexin (Fig. 
16). In particular, the results shown in Fig. 14 and Fig. 15 point towards a key role for 
the N-domain in the TAP2 subunit in the proper assembly of the TAP-associated 
PLC.  
As noted before, calnexin was proposed by others to be a component of a 
TAP/tapasin-precursor-complex that is formed preceding the entry of calreticulin and 
MHC class I into the PLC (Fig. 4) (Diedrich et al, 2001). As the co-isolation of this 
chaperone with 1-2∆N was (besides ERp57 and calreticulin) also dramatically 
reduced when compared to TAPwt, the impeded formation of a proper loading 
complex by 1-2∆N could be due to problems that appear early in the biosynthetic 
assembly of TAP/tapasin-complexes. Surprisingly, experiments on the TAP single 
chains and the tandem transporters indicated that depending on its assembly state, 
TAP1 uses different subregions of its TMD for the interaction with tapasin (Fig. 11A 
and Fig. 12C). That comparable amounts of tapasin and MHC class I were co-
isolated with 1∆N and wild-type TAP1 (Fig. 12C) suggests further that the core TMD 
acts as the sole tapasin-docking site in single expressed TAP1 chains. Thus, in view 
of the findings on 1∆N, TD1/2∆N and TD1∆N/2∆N (Fig. 11A and 12C), it is 
reasonable to speculate that TAP subunit pairing is required for the displacement of 
tapasin from the core TMD to the N-domain of TAP1. Interestingly, a recent study on 
the biosynthetic assembly of the TAP subunits provides evidence that 
heterodimerization of TAP occurs in a process where pre-existing (fully synthesized 
and folded) TAP1 chains associate with newly synthesized TAP2 chains (K. 
Keusekotten, R. M. Leonhardt, S. Ehses and M. R. Knittler, manuscript in 
preparation). Thus, it is tempting to speculate that the rearrangement of tapasin 
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within the TMD of TAP1 is directly induced by the entry of the nascent TAP2 chain 
during the heterodimeric assembly of the transporter. In view of this scenario, the N-
domain in TAP2 might have a critical role in stabilizing the interaction with accessory 
chaperones during the displacement of the tapasin-associated loading complex from 
the core TMD to the N-domain in TAP1. Consequently, its absence may result in an 
irreversible loss of accessory chaperones from the PLC or in the persistent failure to 
stabilize TAP1-associated chaperones during the following loading cycles.  
Nevertheless, the question arises, which function the (additional) tapasin-docking-site 
in the core TMD of TAP1 serves for, as it is apparently not used for the formation of a 
loading complex in the assembled transporter (Fig. 11A). The answer may lie in the 
complex network of interactions that are required for the stable high-level expression 
of the transporter. In particular, several groups could recently show that in contrast to 
TAP1, TAP2 chains have a reduced in vivo-stability when expressed in isolation 
(Antoniou et al, 2002b; K. Keusekotten, R. M. Leonhardt, S. Ehses and M. R. Knittler, 
manuscript in preparation). Thus, it was proposed that TAP1 is required for the stable 
expression of TAP2 and the assembled transporter molecule (Furukawa et al, 1999). 
This is in keeping with observations that the expression level of TAP1 seems to 
control the amount of stable and functional heterodimeric TAP in the ER (Herzer et 
al, 2003; Zhu et al, 1999). TAP1 expression in turn depends on its ability to interact 
with tapasin (Garbi et al, 2000; Tan et al, 2002). This becomes evident by a dramatic 
decrease in the steady state levels of TAP1 (up to 100-fold) in cells that are tapasin-
deficient or express tapasin mutants, which fail to associate with TAP (Garbi et al, 
2003; Tan et al, 2002). Interestingly, the steady state expression level of the 
truncated TAP1 chain 1∆N is not affected at all when compared to wild-type TAP1, 
irrespective whether it is expressed as a single subunit (Fig. 12A) or in conjunction 
with the corresponding TAP2 chain (Fig. 5B). This suggests that tapasin-mediated 
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stabilization of TAP1 does not depend on the ability of this chaperone to interact with 
the N-domain of the chain. Consequently, the stabilization of this subunit is likely to 
occur via tapasin-binding to the core TMD of TAP1 and therefore presumably takes 
place before and/or during the biosynthetic assembly of the transporter molecule. 
 
6.4 Functional expression of TAP lacking both N-regions can be achieved by 
head-to-tail fusion of the two chains linked to one another the connector region 
of MDR1b 
Repeated transfection experiments failed to generate T2 cell lines stably co-
expressing the TAP chain variants 1∆N and 2∆N. That Koch and colleges observed 
nothing comparable in baculovirus-infected insect cells (Koch et al, 2004) is most 
likely due to the fact that the authors used a transient over-expression system for 
their studies. Nevertheless, the experiments shown in Fig. 9, Fig. 10 and Fig. 11 
demonstrate that the “co-expression problem” of 1∆N and 2∆N in T2 cells can be 
solved by a head-to-tail fusion of both truncated subunits linked by the 61 amino 
acid-long connector region of murine MDR1b (Gros et al, 1986). The peptide 
transport activity of TD1/2∆N and TD1∆N/2∆N (Fig. 10C, Fig. 11B and Fig. 11C) 
indicates that the fused TAP subunits are able to form the same functional interfaces 
as they do in heterodimeric wild-type TAP. This strongly supports the hypothesis that 
the structural organization and pairing of the TMDs and NBDs is highly conserved 
between “tandem ABC-transporters” and “two chain ABC-transporters”. The 
connector region of MDR1b and other tandem ABC-transporters shares no 
detectable sequence homology to the N-domains of TAP and is known to act as a 
flexible linker that allows proper folding, pairing and coordinated interaction of the two 
halves of tandem transporters (Hrycyna et al, 1998). Mutations in the connector 
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region of MDR1 can lead to protein instability, misfolding and abrogation of transport 
activity (Hrycyna et al, 1998). Thus, although clearly not essential for the expression 
of single TAP chains (Fig. 12A) or the formation of a functional translocation pore in 
the heterodimeric transporter (Fig. 6B), the N-domains of TAP1 and TAP2 may be 
part of a structural unit in TAP that analogous to the connector region is critical for 
the efficiency of transporter biogenesis by reducing the risk of misassembly and as a 
consequence proteolytic degradation or accumulation of cell-toxic aggregates. This 
view is strongly supported by the observation that complex assembly between 1∆N 
and 2∆N is drastically impaired (Fig. 9A). Interestingly, a very recent study reported 
the construction of two equally functional tandem variants of the homodimeric “half 
size” ABC transporter ABCG2 (Bhatia et al, 2005), which has been implicated with 
the acquisition of multidrug resistance in cancer cells (Lockhart et al, 2003). 
Analogous to the tandem transporters described in this thesis, both variants were 
generated by head-to-tail fusion of two identical ABCG2 subunits. In one of the two 
variants the ABCG2 subunits were directly fused to one another whereas in the other 
variant the connector region of human MDR1 was used as a linker to join both 
chains. As either variant was shown to be clearly active (Bhatia et al, 2005) it seems 
that the presence of a connector region in tandem transporters is at least not 
essential for proper function in general. However, it is noted that ABCG2 has a highly 
uncommon genetic structure when compared to other ABC transporters (including 
TAP) as here an N-terminal NBD is followed by a C-terminal TMD (Doyle et al, 1998). 
Consequently, the domain organization in the ABCG2 head-to-tail fusion gene 
follows the order H2N-[NBD-TMD]-[NBD-TMD]-COOH whereas the order in most 
tandem transporters (including TD1/2∆N and TD1∆N/2∆N) is H2N-[TMD-NBD]-[TMD-
NBD]-COOH. Thus, the situation that the connector region in the ABCG2 fusion 
protein is dispensable for proper folding of the transporter and its substrate 
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translocation activity (Bhatia et al, 2005) may represent a special case that can be 
applied for only a few tandem transporters rather than to reflect a fundamental 
feature of tandem transporters in general. In this context it is interesting to note that 
indeed some fungal tandem ABC transporters like Pdr5p share the same unusual 
domain structure as the constructed ABCG2 fusion protein (Bissinger et al, 1994). 
Thus, one may speculate that this specific class of drug exporters does not require a 
connector region for folding and substrate transport. Nevertheless, a head-to-tail 
fusion construct of TAP with N-terminal TAP2 immediately followed by TAP1 without 
any connector region (H2N-TAP2-TAP1-COOH) is only expressed at hardly 
detectable levels in T2 cells and has no apparent transport activity (J. C. Howard, 
personal communication), indicating (albeit not proving) that the construction of a 
functional TAP tandem transporter indeed requires the presence of a connector 
region for proper assembly of the two homologous halves as observed for the related 
MDR1. 
 
6.5 Proprotein convertases rescue suboptimally loaded MHC class I molecules 
in late secretory compartments 
Characterization of the intracellular MHC class I presentation pathway in cells 
expressing variant 1-2∆N (Fig. 15A and Fig. 15C) showed that in a situation where 
the quality control in the loading complex fails stabilization of ER-exported MHC class 
I complexes can occur during intracellular transport to the plasma membrane. Very 
similar observations were also described for tapasin-deficient cells (Williams, et al, 
2002). Thus, the underlying cellular rescue mechanism does not appear to be 
restricted to a situation of malfunctioning TAP, but in contrast is likely to become 
generally applied by the cell under circumstances where (for whatever reason) 
unstable MHC class I molecules leave the ER and traffic to the plasma membrane. 
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Yet, it is unknown whether this process is advantageous for the cellular immune 
response or rather represents an Achilles heel of the host’s ability to efficiently strike 
against intruding microbes or cancerous cells. As tumours were reported to 
frequently down-regulate the expression of tapasin (Delp et al, 2000; Giorda et al, 
2003; Lou et al, 2005; Raffaghello et al, 2005; Seliger et al, 2003) malignant cells 
may exploit this cellular rescue pathway to ensure sufficient levels of “self peptide”-
presenting MHC class I molecules at the cell surface for evasion of NK cell-mediated 
killing (Moretta et al, 1996). Conversely, as some viruses interfere with the quality 
control of peptide loading in the PLC (Park et al, 2004) this pathway could also 
contribute to a rescue in the class I-mediated presentation of viral peptides and 
consequently to an enhanced clearance of infected cells (see below). Most 
interestingly, the studies depicted in Fig. 21 provide for the first time evidence that 
post-ER stabilization of MHC class I in the cell line T2(1-2∆N) depends on proprotein 
convertase activity, but not on endocytic recycling and/or reloading of MHC class I by 
endosomal processing (Fig. 19). Consistent with this idea the stability of ER-exported 
MHC class I molecules appears to improve as these migrate along the exocytic route 
(Fig. 15C). Thus, it is tempting to speculate that the observed phenomenon reflects 
the exchange by MHC class I of suboptimal (weakly binding) peptide ligands that had 
been loaded in the ER for high affinity peptides in the TGN. These are presumably 
derived from prodomains liberated by the proteolytical activity of furin-like 
convertases (Fig. 24). Several lines of evidence support such a model. First, it is 
known that less stably associated peptide ligands dissociate from MHC class I at 
acidic pH-conditions corresponding to the trans-Golgi network (determined to be 
around 5.0) (Chefalo et al, 2003; Stryhn et al, 1996). Furthermore, at an acidic pH of 
around 5.0 MHC class I molecules are peptide-receptive and can perform efficient 
peptide exchange (Chefalo et al, 2003; Gromme et al, 1999). Second, several 
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Fig. 24 Current working-model for proprotein convertase dependent rescue of MHC class I 
molecules in T2(1-2∆N) cells  
In the wild-type loading complex the central TAP molecule forms a precursor complex (comprising 
tapasin, ERp57 and calnexin (CNX)) via one N-domain and a peptide-loading complex (comprising 
tapasin, ERp57, calreticulin (CRT) and MHC class I) via the opposing N-domain (left column). As 
2-1∆N contains solely one of the two tapasin-docking regions present in TAPwt, a normal PLC can 
only be formed via TAP2 whereas 1∆N lacks any tapasin interaction in the assembled transporter 
(middle column). In T2(TAPwt) and T2(2-1∆N) cells the loading of optimal high affinity peptide 
ligands (red triangle) onto MHC class I is favoured over weakly binding cargo (brown triangle) due 
to tapasin-mediated peptide-editing (1). Thus the generated peptide-MHC class I complexes are 
stable when they traverse the TGN and migrate to the cell surface (6). In contrast, 1-2∆N forms 
altered PLCs that fail to stably recruit accessory chaperones (right column). Consequently, the 
peptide-editing function of the PLC is disturbed (2), which leads to the transfer of low-affinity 
peptides (brown triangles) onto MHC class I. The resulting unstable class I molecules become 
exported from the ER (3) at a normal rate, but loose their suboptimal cargo in the acidic milieu of 
the TGN (4). Proprotein convertases (PC) cleave proproteins along the secretory route and 
thereby contribute to the generation of peptides. Although this pathway is active in all T2 
transfectants, empty MHC class I molecules largely appear solely in the TGN of T2(1-2∆N) cells. 
These are rescued by the binding new PC-dependent ligands (5). As the acidic conditions in the 
late secretory compartments confer high stringency on the MHC class I-peptide interaction, 
complexes that can be formed under these circumstances are highly stable. Following the peptide-
exchange in the TGN of T2(1-2∆N) MHC class I becomes exported (6) and migrates to the plasma 
membrane. 
members of the proprotein convertase family, including furin, PACE4, PC5 and PC7 
reside in the trans-Golgi network or in post-TGN vesicles (Fig. 20C; Seidah et al, 
1998; Wouters et al, 1998), where they process a plethora of endogenous ligands 
including matrix metalloproteinases, integrins, growth factors, receptors, peptide-
hormones and neurotransmitters (Khatib et al, 2002). Following the initial cut, the 
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resulting peptides can be further trimmed by carboxypeptidases (Reznik et al, 2001). 
Of these at least carboxypeptidase D is ubiquitously expressed and localized to the 
TGN (Reznik et al, 2001). This indicates that in the compartments of the late 
secretory route (in most cell types) a whole battery of proteases is capable of 
generating and processing putative class I ligands. Most importantly, the finding that 
the MHC class I surface levels in T2(1-2∆N), but not in T2(TAPwt) or T2(2-1∆N) cells 
are sensitive to the highly specific proprotein convertase inhibitor hexa-D-arginine 
(Fig. 21) provides direct evidence for the involvement of PCs in the rescue of 
unstable MHC class I molecules. This is in line with several recent reports, which 
demonstrate that proprotein convertases can contribute peptides to the repertoire of 
MHC class I-presented epitopes (Gil-Torregrosa et al, 1998; Gil-Torregrosa et al, 
2000; Lu et al, 2001; Zhang et al, 2001). However, it is noted that all studies cited 
above focus on the presentation of individual peptide antigens liberated from 
chimeric constructs that are normally not expressed in the cell. Thus, the contribution 
of PCs to the peptide pool presented by MHC class I was in these studies 
determined under somewhat artificial conditions. In contrast, this thesis describes for 
the first time the influence of proprotein convertases on the bulk population of class I 
ligands derived from naturally occurring intracellular proteins. It should additionally be 
mentioned that MHC class I-presented epitopes liberated from PC-processed viral 
polypeptides have been described (Johnstone et al, 2004), although it is not yet clear 
whether proprotein convertases are essential for the generation of the respective 
peptides. Additionally, the idea that suboptimally loaded MHC class I molecules 
exchange their peptide cargo in the TGN is further supported by the time-course at 
which MHC class I molecules acquire stability in T2(1-2∆N) cells. In particular, the 
stability of a pulse-labeled post-ER class I population in T2(1-2∆N) cells continues to 
improve for clearly more than 3 hours (Fig. 15C). This indicates that a significant 
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fraction of the respective molecules has already reached the plasma membrane or 
has at least entered the late compartments of the secretory route (for comparison: 
the T1/2 for MHC class I surface recovery was determined to be approx. 5 hours (Fig. 
8B)). Taken together a model can be postulated, in which the TGN serves as a post-
ER “checkpoint” of MHC class I processing that rescues unstable MHC class I 
complexes, which otherwise would have a reduced chance to survive on the cell 
surface (Fig. 24). This pathway would maintain high (or depending on the allele at 
least moderate) MHC class I surface levels even under conditions of a malfunctioning 
quality control of peptide loading. The respective epitopes would derive from 
secretory proteins and due to a more limited number of substrates (and perhaps 
proteases) involved, the overall repertoire of presented peptides would be expected 
to be somewhat narrowed when compared to a cell where the conventional class I 
antigen presentation pathway works properly. Nevertheless, since MHC class I-
bound peptides are much shorter in length than the propeptides liberated by PCs, 
efficient MHC class I loading would require further processing by other proteolytic 
enzymes. In particular, proprotein convertase-generated peptides for HLA-B5 are 
predicted to depend at least on C-terminal trimming as the furin-like convertases 
cleave after paired basic amino acids whereas HLA-B5 strongly prefers a 
hydrophobic C-terminal anchor residue (Falk et al, 1995). Although not excluding 
other possibilities, recent studies suggest that carboxypeptidases serve for that 
function (Gil-Torregrosa et al, 1998; Lu et al, 2001). Nevertheless, the question 
arises why peptides generated in the TGN by proprotein convertases can stabilize 
HLA-B5 in T2(1-2∆N) cells whereas the ligands available in the ER obviously cannot. 
It must be considered unlikely that the peptide pool to which PC-activity contributes 
has in general a higher affinity for MHC class I as the peptides generated by the 
proteasome. Rather it is plausible to assume that the acidic environment in the TGN 
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confers high stringency on MHC class I loading and allows only optimal peptide 
ligands to bind (and stay associated) (Fig. 24).  
It is interesting to note that a plethora of viral proteins is processed by members of 
the PC-family, among them gp160 of HIV (Decroly et al, 1997), F-protein of RSV 
(Gonzalez-Reyes et al, 2001), P22 of HBV (Messageot et al, 2003) and gpUL55 of 
HCMV. Furthermore, under conditions of an acute infection viral proteins may 
become highly abundant in the secretory compartments. Thus, as evasion strategies 
of some viruses target tapasin-mediated peptide optimization mechanisms and 
thereby cause the generation of instable MHC class I molecules (Park et al, 2004), 
the proprotein convertase-dependent rescue of MHC class I complexes could force 
the surface presentation of viral peptides. Hence, the alternative pathway of MHC 
class I loading in the TGN may be part of a cellular counter strategy that undermines 
viral efforts to block the antigen presentation machinery.  
Nevertheless, as on the one hand proprotein convertases add peptides to the MHC 
class I-pathway under certain conditions (Fig. 21 and Fig. 24), they cleavage-activate 
viral fusion proteins on the other hand and thereby make an essential contribution to 
the infectivity of the virus (Jean et al, 2000; Kibler et al, 2004). Thus, positive aspects 
of proprotein convertase expression for the cellular immune response are likely to be 
counteracted by a high rate of viral replication. Conversely, a downregulation of PCs 
may result in an overall reduction of infectious viral particles, but may also dampen 
efficient antigen presentation and thereby limit the chance to ultimately eliminate 
infected cells. Seven highly related members of the proprotein convertase family 
have been identified so far (Seidah et al, 1998). Despite some individual 
characteristics they all share clearly overlapping cleavage specificities and substrates 
(Basak et al, 2001; Kibler et al, 2004; Vollenweider et al, 1996). The extensive 
downregulation of at least furin and PACE4 in response to interferons (Fig. 22) is 
 
6. Discussion 106
likely to represent a novel mechanism of innate cell-autonomous immunity that limits 
the rate of viral spread during an acute infection (see above). It is yet unclear at the 
molecular level how the transcription of the respective convertases is switched off 
upon interferon treatment. However, the furin promotor was shown to contain multiple 
binding sites for the transcription factor SP1 (Ayoubi et al, 1994), which is involved in 
the interferon-γ-induced transcriptional repression of the lipoprotein lipase gene in 
macrophages (Hughes et al, 2002). In addition, also the PACE4 promotor was 
reported to comprise binding sites for SP1 (Tsuji et al, 1997). Therefore, SP1 is one 
attractive candidate for mediating the down-regulation of proprotein convertases in 
response to antiviral cytokines. However, that PC7 expression clearly persists upon 
interferon treatment suggests that this protease may continue to supply MHC class I 
with ligands even under conditions of a viral infection. Possibly, the presence of this 
single convertase is not sufficient to allow for an optimal replication of most viruses. 
As several viral proteins require the cleavage at multiple sites for proper maturation 
(Gonzalez-Reyes et al, 2001; Messageot et al, 2003) and some of these may not be 
favoured by PC7, the presence of only one (or only a few) different convertases in 
the TGN may ensure an efficient generation of peptides without allowing for a high 
viral replication rate. Nevertheless, the results shown in Fig. 22 do not rule out a 
possible role for furin and PACE4 in the presentation of viral antigens in the context 
of an infection, as several viruses have been reported to block the interferon 
signalling pathway, among them HCMV (Miller et al, 1998; Miller et al, 1999), 
hepatitis C virus (HCV) (Duong et al, 2004) and varicella-zoster virus (VZV) 
(Abendroth et al, 2000). One possible reason why viruses tend to inhibit interferon-
signalling could be that they require specific proprotein convertases as furin or 
PACE4 (or they require higher levels of PCs in general) for efficient replication and 
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spread. The results presented in this thesis suggest that they may pay a high price 
for the forced (re-)onset of proprotein convertase expression.   
 
7. Summary 108
7. Summary  
The transporter associated with antigen processing (TAP) translocates antigenic 
peptides into the ER for binding onto MHC class I molecules. Tapasin organizes a 
peptide-loading complex (PLC) by recruiting MHC class I and accessory chaperones 
to the N-terminal regions (N-domains) of the TAP subunits TAP1 and TAP2. To 
investigate the function of the tapasin-docking sites of TAP in MHC class I 
processing, N-terminally truncated variants of TAP1 and TAP2 were expressed in 
combination with wild-type chains, as fusion proteins or as single subunits. The 
results indicate that TAP interacts at steady state with MHC class I solely via one N-
domain whereas the opposing tapasin-docking site concomitantly associates with 
calnexin. Strikingly, TAP variants lacking the N-domain in TAP2, but not in TAP1, 
build PLCs that fail to generate stable MHC class I-peptide complexes. This 
correlates with a substantially reduced recruitment of accessory chaperones into the 
PLC demonstrating their important role in the quality control of MHC class I loading. 
However, stable surface expression of MHC class I is rescued in compartments of 
the late secretory route by a mechanism that depends on the proteolytical activity of 
the proprotein convertase family. Finally, it is shown that proprotein convertase 
expression is differentially modulated in response to interferons indicating that 
individual members of this protease family may make distinct contributions to an 
antiviral immune response.  
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8. Zusammenfassung 
Der Peptidtransporter TAP überführt Peptidantigene aus dem Cytosol in das 
endoplasmatische Retikulum (ER). Diese werden anschließend auf MHC Klasse I-
Moleküle geladen. Tapasin spielt eine zentrale Rolle bei der Organisation des 
sogenannten Peptid-Ladekomplexes, welcher neben TAP und MHC Klasse I-
Molekülen auch akzessorische Chaperone, wie Calreticulin und ERp57 enthält. 
Beide Untereinheiten des heterodimeren Transporters, TAP1 und TAP2, interagieren 
mit Tapasin über ihren N-Terminus, die sogenannte N-Domäne. Um die Funktion der 
Tapasin-Bindestellen in den beiden TAP-Ketten zu ermitteln, wurden 
Deletionsmutanten der TAP-Untereinheiten erzeugt, in denen jeweils die N-Domänen 
entfernt wurden. Diese wurden dann entweder gemeinsam mit der komplementären 
wildtypischen Untereinheit, als Fusionsprotein oder als einzelne Ketten in einem 
humanen TAP-negativen Zellsystem exprimiert. Es konnte gezeigt werden, daß der 
Transporter zu jedem gegebenen Zeitpunkt in der Zelle lediglich über eine seiner 
beiden Tapasin-Bindestellen mit MHC Klasse I-Molekülen assoziiert ist. Dagegen 
interagiert die gegenüberliegende N-Domäne mit dem ER-Chaperon Calnexin. 
Weiterhin ergab sich, daß das Vorhandensein der N-Domäne in TAP2, nicht aber der 
korrespondierenden N-Domäne in TAP1 für die Beladung von MHC Klasse I-
Molekülen mit stabil bindenden, hochaffinen Peptid-Liganden essentiell ist. Eine 
TAP-Deletionsvariante, in welcher der N-Terminus in TAP2 entfernt worden war, 
bildete zwar Peptid-Ladekomplexe aus, allerdings zeigten diese eine deutlich 
schwächere Interaktion mit akzessorischen Chaperonen. Im Einklang mit anderen 
Studien verdeutlicht dies die herausgehobene Rolle dieser Chaperone für die 
Qualitätskontrolle der Peptidbeladung von MHC Klasse I-Molekülen. 
Interessanterweise konnte jedoch gezeigt werden, daß die Stabilität suboptimal 
beladener MHC Klasse I-Moleküle nach Verlassen des ERs in späten sekretorischen 
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Kompartimenten wiederhergestellt werden kann. Dieses Phänomen ist abhängig von 
der proteolytischen Aktivität sogenannter Proprotein-Konvertasen, die sich im trans-
Golgi Netz befinden und dort an der Prozessierung einer Vielzahl zellulärer 
Polypeptide beteiligt sind. Daher legen die erzielten Ergebnisse nahe, daß die 
Zunahme der Stabilität mangelhaft beladener MHC Klasse I-Moleküle durch den 
Austausch von Peptid-Liganden erfolgt. Darüber hinaus konnte gezeigt werden, daß 
die Transkription der verschiedenen Proprotein-Konvertasen unterschiedlich durch 
Interferone moduliert wird, was daraufhin deutet, daß unterschiedliche Mitglieder 
dieser Protease-Familie unterschiedliche Aufgaben während einer antiviralen 
Immunantwort übernehmen. 
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